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Abstract 
One of the aims of synthetic biology is the sustainable production of high-value 
compounds and bioenergy molecules. Synthetic biologists exploit fundamental 
engineering principles, such as DNA component standardization, modular genetic 
circuits, and de novo design, to create novel production pathways and products. A well-
characterized host cell serves as the chassis for the system construction; generally, the 
model bacterium Escherichia coli is applied. However, the metabolism and 
characteristics of E. coli are not ideal for all applications. Furthermore, many E. coli 
based systems are patent protected which restricts the use in forthcoming application. 
Acinetobacter baylyi ADP1 is a potential alternative host for synthetic biology. The 
metabolism and genetics of the strain are well-understood, and the engineering of its 
genome is technically straight-forward. The versatile and unusual metabolic pathways, 
including those producing long chain hydrocarbons, can be rerouted, modified, and 
integrated into novel ones. I exploited A. baylyi ADP1 as a model host for the 
production of high-value hydrocarbons, triacylglycerols and wax esters. I employed 
metabolic engineering, novel molecular monitoring tools, and synthetic pathway design 
to improve the production, and to demonstrate the utility of ADP1 as a synthetic biology 
host. In particular, the production of triacylglycerols was improved over 5-folds by 
targeted gene deletions which resulted in redirected carbon flux towards the product 
and elimination of competitive pathways. 
The long-chain hydrocarbon metabolism, including alcohol and wax ester biosynthesis, 
is not yet fully understood. These pathways are regulated through several mechanisms 
sensitive to specific environmental conditions and the cellular states. However, the lack 
of robust and straight-forward analysis tools has restricted the studies of lipid 
metabolism and production kinetics. I developed a simple in vivo tool for the 
investigation of the long chain hydrocarbon metabolism in real-time. The tool is based 
on a light-producing reporter enzyme, bacterial luciferase. The enzyme utilizes a 
specific intermediate of the hydrocarbon synthesis pathway as a substrate for 
bioluminescence production. Initially, the tool was applied for monitoring the wax ester 
metabolism of A. baylyi ADP1. Subsequently, I modified the monitoring tool for studying 
the degradation of alkanes. The studies suggest that the tool can be applied for 
production optimization in different hosts and for a variety of products. I also 
reconstructed the wax ester synthesis pathway of A. baylyi ADP1 by replacing a natural 
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key enzyme with an alternative well-characterized component, enabling a regulated 
production of unnatural wax esters.  
Bioprocess control and scale-up of production systems are challenging. Multispecies 
cultures are suggested to improve the robustness and performance of bacterial 
production processes. I exploited the metabolic versatility of A. baylyi ADP1 to 
construct a rationally engineered synthetic coculture with E. coli. The designed 
coculture exhibited improved biomass and recombinant protein production compared to 
the pure culture of E. coli. 
To conclude, I have shown that the strain ADP1 is a suitable host for synthetic biology 
applications, especially for long-chain hydrocarbon production, the development of 
novel tools for metabolic studies, and for exploiting the existing unusual metabolic 
networks of the cell. Thus, further studies of the remaining challenges related to ADP1 
bioprocess and as-of-yet uncharacterized cell mechanisms, are warranted. 
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Tiivistelmä 
Synteettinen biologia on tieteenala, joka yhdistää insinööritieteet, 
informaatioteknologian, ja molekulaarisen bioteknologian. Synteettisessä biologiassa 
hyödynnetään standardoituja biologisia elementtejä, kuten hyvin tunnettuja DNA-
komponentteja ja niistä koostuvia geneettisiä piirejä, joiden avulla voidaan 
systemaattisesta suunnitella ja rakentaa biologisia laitteita. Hyvin tunnetut työkalut 
mahdollistavat tiedon nopean lisääntymisen ja alan nopean kehityksen. Tämän 
tieteenalan teknologioiden avulla voidaan tuottaa teollisuuden kannalta arvokkaita 
molekyylejä, kuten bioenergiakomponentteja ja uusia älykkäitä lääkkeitä. Biologiset 
laitteet rakennetaan eläviin isäntäsoluihin, jotka toimivat systeemin biologisena 
kehyksenä ja ovat siten myös toimivuuden kannalta merkittävässä asemassa. 
Tunnetuin ja eniten käytetty isäntäsolu on Escherichia coli -bakteeri. Tämä bakteeri ei 
kuitenkaan ole ominaisuuksiensa puolesta optimaalisin vaihtoehto kaikkiin sovelluksiin, 
eikä sen aineenvaihdunta tarjoa mahdollisuutta tutkia kaikkia merkittäviä biokemiallisia 
reittejä. Aineenvaihduntareittien tuntemus on välttämätöntä, kun rakennetaan ja 
optimoidaan uusia tai muokattuja reittejä tärkeiden molekyylien tuottamiseksi.  
Acinetobacter baylyi ADP1 -bakteerikanta on yksi potentiaalisista, vaihtoehtoisista 
isäntäsoluista synteettisen biologian sovelluksiin. Kyseisen bakteerin genomi ja 
metabolia tunnetaan hyvin, ja sen geneettinen muokkaus on helppoa ja suoraviivaista. 
Lisäksi solun aineenvaihdunta on erittäin mielenkiintoinen; kannan luontainen kyky 
tuottaa pitkäketjuisia hiilivetyjä, kuten biopolttoainetuotantoon soveltuvia triglyseridejä 
ja vahaestereitä, tarjoaa hedelmällisen lähtökohdan aineenvaihdunnan tutkimiseen ja 
muokkaamiseen. 
Väitöskirjassani osoitan, että A. baylyi ADP1 -kantaa voidaan hyödyntää synteettisen 
biologian isäntäsoluna ja mallisysteeminä. Paransin tutkimuksessani bakteerikannan 
triglyseridituotantoa metaboliamuokkauksen keinoin: Aineenvaihdunnan mallintamisen 
perusteella identifioitiin geenejä, joiden poistaminen vaikuttaa suotuisasti triglyseridien 
tuottoon. Poistamalla tietty geeniyhdistelmä voitiin eliminoida solunsisäisiä kilpailevia 
reittejä ja ohjata hiilivuo kohti tuotetta. Muokkauksen tuloksena triglyseridituotanto 
parantui noin viisinkertaisesti. 
Pitkäketjuisten hiilivetyjen aineenvaihduntareitit eivät ole vielä hyvin tunnettuja. Tämä 
johtuu osittain siitä, että tutkimukseen tarvittavia yksinkertaisia ja dynaamisia työkaluja 
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ja menetelmiä ei ole ollut saatavilla. Tutkimuksessani kehitin uuden molekulaarisen 
työkalun, jonka avulla pitkäketjuisten hiiliyhdisteiden tuottoa voidaan monitoroida solun 
sisällä reaaliaikaisesti. Työkalu perustuu bakteerilusiferaasientsyymiin, joka tunnistaa 
spesifisesti ko. aineenvaihduntareittien välituotteen, pitkäketjuisen aldehydin, ja reagoi 
sen kanssa tuottaen näkyvää mitattavaa valoa eli bioluminesenssia. Työkalun 
toimivuus osoitettiin tutkimalla A. baylyi ADP1 -kannan vahaesterimetaboliaa, mutta 
sitä voidaan soveltaa myös muihin organismeihin ja tuotteisiin. Hyödynsin työkalua 
myös mukauttamalla sen detektoimaan alkaaneja ja diesel-peräisiä yhdisteitä sekä 
näiden yhdisteiden hajotusta.  
Rekonstruoin tutkimuksessani myös ADP1-kannan vahaesterituottoreitin: yksi reitin 
avainentsyymeistä korvattiin hyvin tunnetulla DNA-komponentilla, jota käytettiin täysin 
uudessa tarkoituksessa. Reitin uudelleensuunnittelun ja -rakentamisen tuloksena 
pystyttiin tuottamaan kontrolloidusti synteettisiä vahaestereitä, jotka eroavat 
ominaisuuksiltaan ADP1:n luonnollisista vahaestereistä. 
Yksi synteettisen biologian haasteista on rakennettujen systeemien toimivuus ja 
stabiilius suuren mittakaavan prosesseissa. Prosessit, joihin osallistuu useita 
yhteistyössä toimivia bakteerikantoja, ovat mahdollisesti vakaampia, sillä oikeanlaiset 
populaatioyhdistelmät edistävät suotuisten olosuhteiden säilyttämistä ja prosessin 
suorituskykyä. Tutkimuksessani osoitan, että ADP1-kantaa voidaan hyödyntää myös 
täysin uudella tavalla E. coli -pohjaisissa yhteiskasvatuksissa; geneettisen 
muokkauksen tuloksena luotiin synteettinen, keinotekoisesti symbioottinen 
yhteiskasvatus, jossa biomassan ja rekombinanttisen proteiinin tuotto parani verrattuna 
E. coli -puhdasviljelmään. 
Yhteenvetona totean, että A. baylyi ADP1 soveltuu synteettisen biologian 
isäntäorganismiksi erityisesti osa-alueilla, jotka liittyvät pitkäketjuisten hiiliyhdisteiden 
tuottamiseen sekä tutkimiseen ja jotka hyödyntävät solun omia aineenvaihduntareittejä. 
Kannan bioprosessin kehittäminen sekä toistaiseksi tuntemattomien mekanismien 
karakterisointi asettavat haasteita, mutta bakteerin moninaiset ominaisuudet ja 
potentiaali puoltavat sen jatkokehittämistä synteettisen biologian sovelluksiin.   
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1 Introduction 
Synthetic biology is a new emerging discipline combining life sciences, information 
technologies, and engineering. Synthetic biology seeks rational and sustainable 
solutions for improving human health, promoting energy self-sufficiency, producing 
important commodities, generating novel molecules and products with new features, 
and addressing environmental and agricultural issues. The most acute targets include 
reducing and preventing food shortage, developing novel drugs for complex diseases, 
and compensating for the depletion of fossil energy sources with green energy 
technologies.  
The fundamental philosophy of synthetic biology lies in redesigning biology, applying 
standard engineering principles, methods, and organisms. This ideology redefines 
biological systems and particularly the organisms, emphasizing their properties in 
terms of design, programmability, and modularity, rather than according to the 
taxonomical or microbiological characteristics or status. The new engineering principles 
and methodologies of synthetic biology have led to a tremendous increase in 
complexity and novelty of biocompounds and pathways, compared to typical products 
obtained by means of conventional genetic engineering, such as single proteins or 
small metabolites. However, increased complexity requires more comprehensive 
design and computation. Instead of the extensive and consuming work of trial and 
error, synthetic biology aims at providing tailored and well-characterized working 
platforms for construction of newly designed cells performing determined tasks. In 
addition, robust amenable monitoring tools and functional cellular working platforms are 
required to fulfill the increasing demands of the designed biological systems. 
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This thesis reviews some of the most important technologies, engineering principles, 
achievements, and challenges of synthetic biology, the main focus being on prokaryotic 
systems. Chapter 2 gives a general overview of what synthetic biology is, whereas 
Chapters 3 and 4 focus on more specific research topics, bioenergy production and 
multicellular systems. As a reflection of the potential deficiencies and gaps of the field 
emerged by the current literature, Chapter 5 outlines the hypotheses and objectives of 
my study. Chapters 6 and 7 summarize the methods and results presented in the 
original papers I-V and discuss the research outcomes and future prospects in the 
context of the current state of synthetic biology research.   
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2 Synthetic biology revolution 
The discovery of restriction enzymes in the 1970’s gave birth to recombinant DNA 
technology and molecular cloning, ushering in a discipline of modern biotechnology. An 
early success in the field is the production of recombinant human insulin in engineered 
Escherichia coli. These new technologies led to dramatic development in engineering 
microbial cells for producing important commodities for pharmaceutical and chemical 
industries, such as novel drugs, vitamins, antibodies, and fine chemicals.  
Roughly a decade later, the development of DNA sequencing techniques allowed the 
first complete genome sequence of an organism to be announced in 1995 
(Haemophilus influenzae) (Fleischmann et al. 1995), followed by the first drafts of 
human genome in 2000 (Venter et al. 2001). The rise of ‘scale-up’ systems biology 
brought computer scientists and biologists together, expanding the possibilities to 
combine experimental and computational data (Westerhoff and Palsson 2004; Lanza et 
al. 2012). At the same time, the term synthetic biology became established (Endy 
2005), emphasizing the urge for rational engineering, control, and programmability of 
newly designed cells; the traits lacking from conventional genetic engineering. During 
the past decade, the field and scope of synthetic biology has grown massively and 
made its breakthrough recognized largely by scientific communities as well as 
governmental and industrial players. 
The idea of computational design and construction of regulatory circuits performing 
desired functions became one of the central concepts of synthetic biology. The first 
synthetic toggle switch (Figure 2.1) was constructed in 2000, performing two-state 
transcriptional regulation for expression of fluorescent protein (Gardner et al. 2000).  
2 SYNTHETIC BIOLOGY REVOLUTION 
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FIGURE 2.1.The toggle switch constructed for on/off gene expression via dual-repressor 
system. In the circuit, only one of the two repressor genes is active at a given 
time, resulting in a stable transcriptional state defined by environmental 
stimulus (IPTG, Heat). Modified from (Gardner et al. 2000). 
Growing interest in engineered genetic switches analogous to electrical circuits has 
resulted in development of more sophisticated auto-regulatory feedback modules and 
oscillators, and devices displaying Boolean logic gate behavior (see chapter 2.1.1). The 
first circuits based on cell-cell communication were published shortly after, giving 
impulse to study and engineer synthetic microbial cocultures (Bulter et al. 2004). 
An interdisciplinary community of synthetic biologists had rapidly evolved, consisting of 
molecular biologists, chemists, computer scientists, and engineers. The first official 
meeting for Synthetic Biology (SB1.0) was held in 2004 at the Massachusetts Institute 
of Technology (MIT), USA. The same year another notable event – soon becoming a 
tradition – iGEM (International Genetically Engineered Machine) competition took place 
(http://igem.org/). The rapidly developing techniques produced a tremendous amount of 
new data, which soon led to an open-access philosophy within the community. As an 
example of the communal approach, The Registry of Standard Biological Parts was 
established in 2003, providing standard DNA components and devices for academic 
researchers free of charge (http://parts.igem.org/). At the moment, more than 15 000 
parts are registered.   
Whole-genome engineering was taken to the next level when a complete genome of 
Mycoplasma genitalium was synthesized by scientists of J. Craig Venter Institute 
(Gibson et al. 2008). Subsequently, Venter and colleagues created a viable synthetic 
cell with artificial genome of a size 1.1 Mbp, exploiting chemical synthesis and novel 
DNA assembly techniques (Gibson et al. 2010). After the first decade of the 
millennium, the scientists had taken the first steps toward the ultimate goal, a 
completely programmable cell with desired functions and characteristics. 
2 SYNTHETIC BIOLOGY REVOLUTION 
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2.1 Engineering principles 
Synthetic biology is all about design, rationalizing the complexity of natural systems by 
applying the key concepts of engineering. The main principles of synthetic biology 
involve standardization, specification, compatibility, modularity, and simplicity. 
Systematic design is described as a continuous cycle including a computer aided 
modeling, the implementation of the biological system, and testing and validation, 
finally leading to detailed specifications of the system (Baldwin et al. 2012). 
Standardized biocomponents can be assembled to create synthetic devices performing 
defined functions and devices comprise larger systems conducting complex tasks 
(Figure 2.2). 
 
FIGURE 2.2. The hierarchy of creating synthetic biology circuits and systems from standard 
parts. Modified from (Marchisio and Stelling 2009) 
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2.1.1 Standard parts 
Bioparts are pieces of DNA encoding designed biological functions. The first approach 
to facilitate a straight-forward engineering of biological systems was the creation of the 
BioBrick standard (Shetty et al. 2008). The well-characterized and compatible DNA 
components comprise a vast collection of a variety of reporters, enzyme coding genes, 
regulatory elements, degradation tags, multienzyme complexes, and ready-made 
pathways to ease the cellular engineering. The package also includes tailored 
protocols for BioBrickTM cloning, based on standard vectors and restriction sites. The 
number of deposited individual bioparts, or ”DNA components”, along with committed 
laboratories increase continuously. The Registry of Standard Parts serves as a 
reservoir for the defined DNA components, enabling the construction of genetic devices 
and systems of increasing complexity (iGEM.org). 
For part standardization, a comprehensive characterization with defined system 
specifications is carried out to produce a technical ‘datasheet’. The datasheet contains 
details such as the part number, static performance, a dynamic response, the used 
chassis, part compatibility, and reliability (Figure 2.3). The datasheet provides a 
general description and summary of characteristics of the part or device, enabling a 
straight-forward reuse of the component. (Canton et al. 2008) However, as a time-
consuming protocol, the in vivo part characterization remains a bottleneck in rational 
and predictable engineering. An alternative part standardization approach has been 
introduced, completely based on in vitro characterization of the DNA regulatory 
elements exploiting E. coli cell-free extract (Chappell et al. 2013). 
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FIGURE 2.3. An example of a technical datasheet for a standard biological part (Canton et 
al. 2008). Open access. 
Despite the attempts to control and instruct the part characterization, the concept of 
Canton et al. seem idealistic; the open access policy and the vast number of different 
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depositors have resulted in significant fluctuations in the quality and functionality of the 
deposited parts and devices in the registry. In addition, predicting the compatibility of 
different parts and especially the part function in different conditions and hosts has 
turned out to be very problematic.  
Recent advances in de novo DNA synthesis technologies have enabled a precise 
design and realization of modified and optimized genes for reasonable prices. 
Synthetically tailored genes are especially convenient for protein engineering (Fowler 
et al. 2010; Kim et al. 2013), orthogonal gene expression systems (Rhodius et al. 
2013), and customized pathways with synthetic control elements (Temme et al. 2012). 
Another approach to create new DNA components is ‘part mining’ using metagenomic 
libraries as source for the resynthesis of novel bioparts (Stanton et al. 2014). 
Altogether, if synthetic biologists seek standard parts with maximal orthogonality and 
predictability, de novo designed and synthesized bioparts may be the only practical 
way to increase the reliability of the part-based systems.      
2.1.2 Synthetic gene circuits 
Synthetic genetic circuits are functional entities performing defined tasks (Sprinzak and 
Elowitz 2005; Brophy and Voigt 2014). Circuit design is preferably assisted by 
computational tools (Clancy and Voigt 2010; MacDonald et al. 2011; Rodrigo and 
Jaramillo 2013) and well-characterized parts serve as building blocks for circuit 
modules (Weiss et al. 2003; Voigt 2006; Mutalik et al. 2013). The increasing complexity 
of bottom-up engineered gene networks requires a rational approach to design and 
predict the circuit behavior (Mukherji and van Oudenaarden 2009).  
Synthetic regulation is essential, since many natural genes and gene clusters are silent 
unless induced by a specific molecule or conditions that can be inconvenient or 
unknown (Frasch et al. 2013). Circuits can be regulated at either transcriptional or post-
transcriptional level. In digital transcriptional circuits, input and output promoters define 
the expression state to be simply either ON or OFF, and the circuit performance can be 
monitored using reporters such as fluorescent proteins (Wang et al. 2011). Digital 
circuits can be built based on logic gates with AND, NAND, OR, NOT, or NOR gates 
according to Boolean logic (Figure 2.4). In principle, Boolean logic gates consist of two 
or more input signals and return a single output, namely “true” or “false”. Dynamic 
circuits, such as oscillators, are more difficult to screen and monitor, and thus mainly 
proof-of-principle systems have been described (Elowitz and Leibler 2000; Stricker et 
al. 2008). Promoter architectures acting as circuit regulators typically involve DNA 
binding proteins such as LacI, LuxR, TetR or AraC or combinatorial approaches 
2 SYNTHETIC BIOLOGY REVOLUTION 
 
9 
 
exploiting them (Cox et al. 2007), but also RNA molecules (Lucks et al. 2011), 
metabolites or even changes in environmental stimulus (Levskaya et al. 2005; Tabor et 
al. 2011) can serve as transcription regulators.  
 
FIGURE 2.4. An example of an orthogonal logic NAND gate constructed in E. coli. Reporter 
protein (GFP) production is ON unless both external signals (IPTG and Arab.) 
are given. The dynamic range can be fine-tuned using modified RBS (rbs34, 
rbs30). Modified from (Wang et al. 2011). 
Post-transcriptional circuits typically involve interactions between non-coding RNAs 
and DNAs, proteins, or small molecules (Isaacs et al. 2004). RNAs are naturally 
modular multifunctional molecules possessing unique sequence-specific characteristics 
at both structural and functional levels, thus serving as a useful platform for the design 
and evolution of novel type of regulatory, control, and sensor devices (Liang et al. 
2011; Isaacs 2012; Mutalik et al. 2012). 
Regulatory devices functioning through protein-protein interactions and allosteric 
regulatory systems enable direct and dynamic spatio-temporal regulation of a protein 
function in cells (Grunberg and Serrano 2010; Olson and Tabor 2012). Post-
transcriptional regulation potentially puts less stress and burden on cells, which can be 
crucial in larger circuit designs. 
Genetic circuits hold huge potential for future applications in the fields of biomedicine 
and biotechnology (Lu et al. 2009). Ideally, circuits could be used for programming cells 
displaying precisely timed regulatory systems sensitive to specific signals, molecules, 
or environmental changes. Connected circuits constitute larger genetic programs, and 
the most complex recently reported circuits have involved up to 11 regulatory proteins 
and 38 additional genetic parts (Moon et al. 2012). However, the described synthetic 
systems are still limited in complexity compared to natural systems. In order to build up 
more complex circuits with broader dynamical range several major challenges must be 
overcome. For example, more efficient and precise design tools must be developed for 
obtaining correctly balanced systems. In addition, more robust monitoring tools with  a 
wider range of suitable reporters are required to screen for circuits with optimized 
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performance. Also, a better understanding about factors affecting the performance of a 
circuit and individual components within the context is required, and advances in 
technologies for building up larger circuits involving several devices and components 
are needed (Brophy and Voigt 2014). Moreover, even well-designed and tuned circuits 
often suffer from instability and loss-of-function in long term use (Sleight et al. 2010a).  
Genetic circuits are typically very sensitive to the cellular and environmental context. 
Cross-talk between exogenous and endogenous cellular systems can decrease the 
predictability and robustness of circuits and individual parts in cells (Cardinale and 
Arkin 2012). Thus orthogonal, i.e. isolated expression systems uncoupled from cellular 
regulation are generally a more preferable approach. Orthogonal expression can be 
defined either at cellular level as a host independent expression system diminishing 
any interaction between exogenous and endogenous reactions, or at circuit level, 
implicating an independent transcriptional regulation of different gates, devices, or 
modules in parallel. For example, an orthogonal gene expression pathway in E. coli 
based on specific transcription-translation machinery recognizing only defined 
sequences in DNA and mRNA was previously introduced (An and Chin 2009). Several 
other tools for orthogonal regulation have been also developed and introduced (Rao 
2012). For complex circuits, however, the number of well-known uncorrelated 
transcription factors is currently insufficiently low, limiting the circuit size. Part mining 
(Stanton et al. 2014), design and construction of novel regulatory elements, and 
evolution of existing transcription factors (Kamionka et al. 2004) are applied for 
facilitating the construction of orthogonal circuits consisting of a large number of 
elements.    
During the last decade, a wide-ranging set of different circuit designs were introduced. 
However, fundamental limitations still exist, thus preventing the final breakthrough and 
full-fledged exploitation of the synthetic programs. For example, constructing a 
functional and predictable circuit is still largely conducted by trial and error, which in 
practice means the screening of tens, hundreds, or even thousands of differentially 
constructed circuit candidates. The screening is dependent on convenient assay 
methods or sophisticated flow cytometry instrumentation exhibiting high-throughput cell 
sorting, as for partly limiting the circuit range and function. Moreover, the current 
systems often suffer from “a proof-of-principle syndrome”; the scale-up of circuits is still 
insufficient as the circuits operate correctly only at optimized conditions and in a 
defined cell environment. Other problems restricting the circuit robustness include a 
potential toxicity to cells, metabolic loading, inaccurate modeling, and lack of analysis 
and design tools. 
2 SYNTHETIC BIOLOGY REVOLUTION 
 
11 
 
A representative example of the challenges in circuit design is the rebuilding of the 
nitrogen fixation gene cluster in Klebsiella oxytoca (Temme et al. 2012). The cluster 
containing 20 genes in seven different operons was “refactored”. In the process, all the 
known and hidden natural regulatory elements, noncoding DNAs, and nonessential 
genes were removed. The genes were reorganized into new operons that function 
under the regulation of synthetic elements. The resulting synthetic cluster contained 89 
individual genetic parts. The maximal nitrogenase activity exhibited by the refactored 
system was approximately 7 % of that of the wild type system, and only 2 % when 
expressed in a non-native host, namely E. coli (Temme et al. 2012). More previously, 
the modularity of the system was exploited in creating genetic permutations to further 
investigate and optimize the cluster functionality (Smanski et al. 2014). More than a 
hundred different variants of each operon were combinatiorally assembled and 
analysed, and the information was applied in further design cycles. Eventually, a 
nitrogenase activity of 57 % of the wild type system in K. oxytoca could be achieved. 
This variant recovered 7 % activity in E. coli, whereas a variant specifically optimized 
for E. coli yielded nearly 20 % activity. The study demonstrates the complexity of 
redesigning highly evolved natural systems and the difficulty of maintaining and 
determining the functionality of corresponding synthetic systems, especially if non-
native hosts are used. Nevertheless, only two hosts were tested in the described study; 
thus it would be very interesting to investigate, how the activity range of the original 
refactored design would have changed in a broader range of different cellular 
environments. In another words, could choosing the “right” host in some cases 
compensate for the heavy optimization process?     
In opposite to building up circuits from scratch, integrated circuits directly exploit the 
host machinery and metabolism to carry out the functions (Nandagopal and Elowitz 
2011). Integration can occur at different levels from partially autonomous synthetic 
circuits to rewired or completely integrated pathways (Figure 2.5). Integrated synthetic 
circuits can improve functionality, allow more complex design, and broaden the 
usability of single bioparts in new contexts.   
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FIGURE 2.5. Integration of synthetic pathways to cellular environment. Modified from 
(Nandagopal and Elowitz 2011).   
     
2.1.3 Overview of recent DNA assembly and genome engineering 
methods 
An increasing number of novel methods for a rapid, reliable, and simple assembly of 
DNA components, and comprehensive genome engineering were introduced during the 
past decade. A dramatic drop in de novo DNA synthesis prices has changed the focus 
of molecular cloning from DNA restriction/ligation based protocols towards a more 
comprehensive design of seamless gene cassettes, complete pathways and even 
genomes. Figure 2.6 presents the frequency of use of recent DNA assembly methods 
in the field of synthetic biology in 2013.  
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FIGURE 2.6. The frequency of use of recent DNA assembly techniques in 2013. Modified 
from (Kahl and Endy 2013). 
Even though not being the most modern and convenient method for a rapid assembly 
of standard parts, the BioBrickTM cloning is still widely in use and can be granted as a 
forerunner to the upcoming approaches. It is based on specific restriction sites (namely 
EcoRI-NotI-XbaI-(-)-SpeI-NotI-PstI) present in all standard vectors and BioBricks, 
enabling a sequential addition of several parts to the same vector. As an advantage, 
the method does not require DNA amplification or design/use of oligonucleotides when 
available parts and vectors are exploited. However, for practical reasons the size and 
complexity of the insertion is quite limited, and the step-by-step addition of parts is 
time-consuming, and thus not significantly different from conventional molecular 
cloning. 
Probably the most revolutionary and today the most widely used DNA assembly 
method, Gibson assembly, was introduced in 2009 (Gibson et al. 2009). The method is 
based on overlapping sequencing in amplified target DNA fragments which are joined 
together by T5 exonuclease, DNA polymerase, and heat-labile ligase in a one-step 
isothermal reaction (Figure 2.7). The method requires specific synthesized 
oligonucleotides (or genes) for each insert fragment. This fast and straight-forward 
method is especially convenient for cloning several components simultaneously and for 
very large DNA fragments. 
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FIGURE 2.7.The Gibson Assembly method. The one-step reaction is carried out 
isothermally in 50 C exploiting a 5’ exonuclease, a DNA polymerase and a 
DNA ligase (here; T5 exonuclease, Phusion polymerase and Taq ligase, 
respectively). Target DNA fragments (synthesized or amplified by PCR) share 
an overlapping sequences that are treated with the exonuclease to create 
overhangs in the 5’ ends. Once the complementary 3’ overhangs anneal, the 
DNA polymerase and ligase fill and seal the gap, while the heat-labile 
exonuclease becomes inactivated.  
Other notable in vitro DNA assembly methods include In-Fusion (Clontech) (Sleight et 
al. 2010b), SLIC (Sequence and Ligation Independent Cloning) (Li and Elledge 2007), 
CPEC (Circular Polymerase Extension Cloning) (Quan and Tian 2014), GoldenGate 
(Engler and Marillonnet 2013), and USER (Uracil-Specific Excision Reagent; NEB) 
(Nour-Eldin et al. 2010). Recently, a biotechnology company DNA2.0 introduced a new 
promising method, Electra Vector System IP-free® cloning 
(http://www.prweb.com/releases/2013/6/prweb10802605.htm). The developers promise 
“a simple, PCR-free, one-tube universal cloning process that can be performed in a 
five-minute bench-top reaction with the fidelity of a restriction-based cloning system”. 
The method is based on a commercial reaction mixture and standard vectors. Most 
importantly, the use of the method is not restricted by intellectual property issues, 
enabling the utilization of the method also in industrial and commercial applications 
without a license. 
In general, in vitro assembly methods are faster, more stable, and easier to use 
compared to in vivo methods. At the moment, the bottleneck of in vitro methods is the 
amplification step, which is more prone to errors than cellular replication, and not 
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generally suitable for amplification of fragments as large as genome-size. For example, 
by exploiting the efficient DNA uptake and recombination machinery of S. cerevisiae 
whole genomes (to date up to 1.8 Mb (Karas et al. 2013)) can be constructed and 
amplified in the yeast cell (Gibson 2011; Benders 2012). 
In addition, efficient tools for whole-genome engineering have been developed. MAGE 
(Multiplex Automated Genome Engineering) is an in vivo method for editing and 
evolving the host genome (Wang et al. 2009), thus far mostly applied in E. coli. By 
MAGE, broad sequence diversity can be generated at many targeted genome locations 
in a large population of cells at high efficiency. Modifications in the genome are 
achieved by repeatedly introducing the designed fragments of synthetic DNA (oligos) 
targeted at the lagging strand of the replication fork in DNA replication, thus resulting in 
allelic replacement. The recombination is mediated by a bacteriophage λ-Red ssDNA-
binding protein β. The technologies have enabled the introduction of “genome 
rewriting”, demonstrated recently in E. coli: all the stop codons TAG were replaced with 
TAA, giving insights to possibilities for expanded biological functions, protein diversity, 
and viral resistance in genetically recoded organisms (Lajoie et al. 2013). Recently, a 
derived MAGE method, yeast oligo-mediated genome engineering (YOGE), has been 
introduced to S. cerevisiae (DiCarlo et al. 2013). For higher organisms, a revolutionary 
CRISPR-Cas9 (Cong et al. 2013) system based on a natural immune response to short 
RNAs has proven its power, and holds potential for future gene/genome therapeutics. 
2.1.4 Synthetic biology and metabolic engineering 
One major approach to realize synthetic biology is metabolic engineering. The more 
specific goal of metabolic engineering is to develop methods for designing, analyzing, 
and optimizing metabolic networks, typically with the objective of finding targets for 
engineering the cell factories (Bailey 1991; Nielsen et al. 2014). The directed and 
specific modifications of metabolic pathways are introduced to cells for an improved 
synthesis of products. Improving the host cell can involve strategies for broadening the 
substrate range, improving product/substrate tolerance, improving productivity or yield, 
or accelerating the cell growth rate. The systems biology driven approach exploits the 
computational analysis of metabolic models and simulations to calculate and redirect 
fluxes within the cell. To date, probably the most notable achievement in the field of 
metabolic engineering is the reconstruction of a synthesis pathway for the production of 
an anti-malaria drug precursor (Martin et al. 2003). As a result of years of optimization, 
the process was further developed for the commercial production of Artemisinin in 
metabolically engineered yeast (Paddon et al. 2013).  
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Metabolic engineering includes a comprehensive engineering of the essential pathways 
for converting the substrates to products. Foundational elements encompass the 
determination of pathway fluxes of both synthetic and native routes, genome-scale 
modeling for identifying optimal gene expression profiles and gene modulation targets, 
as well as the kinetic and thermodynamic analysis of pathways for identification of 
bottlenecks (Stephanopoulos 2012).  
While metabolic engineering is concentrated on manipulating and combining natural 
biochemical pathways, synthetic biology aims at reprogramming cellular behavior and 
creating advanced modular systems for novel products as of yet nonexistent in nature. 
However, synthetic biology and metabolic engineering are highly synergistic 
disciplines, as presented in Figure 2.8, and on the edge of comprising a 
comprehensive toolbox with efficient methodologies, tools, and intellectual scientific 
information. 
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FIGURE 2.8. The interface of metabolic engineering and synthetic biology.  
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2.2 Chassis 
2.2.1 Well-defined organisms as cellular frameworks 
In order to obtain an unambiguous response of a standardized component, and to 
understand the function of natural and non-natural circuits in a cellular environment, a 
host cell in synthetic biology must provide a specified, tractable, predictable, and well-
defined working platform. Basically, the host cell, i.e. chassis, serves as a framework 
for the installation of man-made biological devices. However, even though the number 
of complex program designs is increasing, only limited information is available for 
defining the chassis.  
Designing the genome, genes, and the integration of components into the host are 
crucial elements in the generation of functional and comprehensive biological systems. 
However, even the simplest natural pathways comprise a network of thousands of 
interactions at both transcriptional and post-translational levels. Thus orthogonal 
expression, as discussed in Chapter 2.1, is one of the major challenges in maintaining 
the fabricated system analogous to the original design. Whole-genome engineering 
and streamlining of the host, briefly discussed in the next subchapter, increase the 
level of orthogonality and thus the predictability of non-native cellular processes. On 
the other hand, the chassis can serve as a fruitful platform for constructing complex 
pathways with less effort of fabrication, and an intentional integration of non-natural 
components to the host metabolism can broaden the possibilities to exploit individual 
parts in novel ways.    
2.2.2 From minimal genomes to synthetic cells 
Minimal genomes help us better understand and predict cellular systems. The 
fundamental problem behind the construction of ultimately reduced genomes lies in the 
definition of ‘minimal genome’, which inevitably is specified by the environmental 
conditions, defined level of cell functionality and fitness, and the ability to perform 
specific tasks. The most notable attempts to establish minimalistic cells by a top-down 
approach include the engineering of M. genitalium (Glass et al. 2006) and E. coli 
(Posfai et al. 2006; Hirokawa et al. 2013) genomes.  
Nowadays, genome reduction, or synthetic genomics, is more considered as a tool for 
an increased functionality of a cell rather than aiming at as a small genome as 
possible. As one of the goals of synthetic biology is to increase the level of robustness 
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and functionality of a host cell, genome reduction is seen as an iterative method of 
finding the optimal set of essential genes to facilitate the desired functions of a 
programmed cell (Danchin 2012; Leprince et al. 2012b). Streamlining the host genome 
reduces the unnecessary or counterproductive reactions, and simplifies the interactions 
between cellular components. Genome reduction thus promotes the redesign of an 
optimal chassis enabling ‘plug-and-play’ engineering and takes a step closer towards 
an ultimately synthetic and artificial cell.  
At present, the design principles consider maintaining cellular properties such as 
fitness near to the one of the wild type strains, and more stable, flexible, and evolvable 
production platform with less redundancy. More specifically, the genome streamlining is 
concentrated on removing introns (in eukaryotes), tRNA genes, regulatory elements, 
transposons, and DNA repeat sequences. Novel genome engineering tools, such as 
MAGE and inducible evolution system SCRaMbLE (synthetic chromosome 
rearrangement and modification by loxP-mediated evolution) are employed (Dymond et 
al. 2011). An international on-going project called Sc2.0 is currently working on building 
up the first synthetic yeast genome by a bottom-up approach (Annaluru et al. 2014) 
(http://syntheticyeast.org/sc2-0/). The project aims at increasing fundamental 
knowledge on for example chromosome properties, genome structure and 
organization, the function of RNA splicing and small RNAs, and distinction between 
prokaryotes and eukaryotes. Furthermore, the resulting ‘synthetic yeast’ would possess 
unlimited possibilities for practical use in the field of synthetic biology. Advances in 
genome design and construction will allow us to fabricate minimal cells that can serve 
both as high-capacity test-beds for fundamental genomic studies and as a chassis for 
the installation of programmed circuits.  
2.2.3 Alternative hosts for synthetic biology 
The choice for an optimal chassis is dependent on multiple factors. Straight-forward 
genome engineering and efficient regulatory structure are evident requirements for a 
cell platform, but also other biophysical characteristics, such as metabolic resources, 
exploitable pathways, and robustness in challenging bioprocesses are essential (Foley 
and Shuler 2010; Fisher et al. 2014).  
The most conventional work-horse of all time is beyond dispute E. coli, exploited both 
as a model strain for prokaryotic systems and in commercial applications for production 
of a variety of important biocompounds such as recombinant proteins (Huang et al. 
2012), commodity chemicals (Yim et al. 2011; Chen et al. 2013), and drug molecules 
(Martin et al. 2003). The cumulative and comprehensive knowledge regarding E. coli 
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genome (Blattner et al. 1997; Baba et al. 2006) among other –ome levels information 
(Han and Lee 2006; Ishii et al. 2007) and bioprocess technologies (Lee 1996) has 
ensured the status as a cellular framework also for synthetic biology.  
E. coli serves as a convenient host platform, but as the scope of synthetic biology 
continuously expanding, domestication of other potential bacteria could provide certain 
advantages with regard e.g. to broader metabolic landscape, catalytic activity, and 
tolerance to chemicals and products. To cite an article of Nikel et al. (2014): “is this 
organism [E. coli] really the only bacterium that can be used in both fundamental 
synthetic biology and applied biotechnology?” To explore this, the following 
subchapters introduce some alternative bacterial hosts and describe their most 
important characteristics in terms of synthetic biology, the main focus being on 
Acinetobacter baylyi ADP1. For comparison with E. coli, some key features of the host 
candidates are collected in Table 2.1.  
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TABLE 2.1. Comparison between the model hosts Escherichia coli, Bacillus subtilis, Pseudomonas putida , and Acinetobacter baylyi  ADP1.
E. coli (K12) B. subtilis (168) P. putida (KT2440) A. baylyi  (ADP1)
Natural environment gastrointestinal tracts, water env. soil, water env., plant rhizosphere soil, plant rhizosphere soil, water environment, human skin
gastrointestinal tracts
Genome size 4.6 Mbp, 4288 CDS 4.2 Mbp, 4100 CDS 6.2 Mbp, 5420 CDS 3.6 Mbp, 3325 CDS
Genomic complexity Lot of repeat sequences, genes are 25 % duplicate genes Lot of repeat sequences, genes scattered no repeats, genes oriented as clusters 
scattered all  over the genome and 'catabolic islands'
Metabolic model available available available available
     Genes; reactions 1445; 2286 1103; 1437 900; 1071 774; 875
Databases EcoliWiki, EcoCyc SubtiWiki, BsubCyc Pseudomonas Genome Database AcinetoScope (in MicroScope)
Generation timea 40 min. 95 min. 100 min. 35 min. 
Temperature range for 30-38 °C 25-35 °C 18-30 °C 20-38 °C
efficient growth
Substrate utilization
     Substrate range narrow; simple sugars wide; simple and complex wide; sugars, organic acids, arom. comp., wide; sugars, organic acids, arom. comp.
carbohydrates, peptides long chain hydrocarbons, alcohols etc. long chain hydrocarbons, alcohols etc.
    typical aer./anaer. byproducts CO2 / acetate CO2 / lactate, acetate CO2 / - CO2 / - 
Natural products ethanol, hydrogen antimicr. compounds, 2,3-butanediol polyhydroxyalkanoates, antimicr. comp., Triacylglycerols, wax esters, cyanophysin, 
biosurfactants biosurfactants
Pathogenicity to humans wild type strains none; potentially probiotic none none
Generally regarded as safe (GRAS) approved approved approved N/A
Antibiotic sensitivityb sensitive to common antibiotics sensitive to common antibiotics limited sensitivity sensitive to common antibiotics
Genetic tools widely available available available available
     Promoters e.g. T5, T7, Lac, tet, BAD e.g. T5, T7, Lac, tet, BAD (as in E. coli ) Lac, tet, BAD T5, T7, Lac, BAD
Transformability electroporation, calcium chloride treat. natural competence, electroporation electroporation natural competence, electroporation
Tolerance to toxic compoundsc weak good very good good
Foundational research extensive extensive well established well established in defined fields
Existing applications, e.g. numerous
1,3 numerous1 several2,3 few3
Commercial availability heavily patented, a true issue widely patented patents exist very few patents, not an issue
regarding patents
aMinimal medium, glucose or succinate (ADP1) as a sole carbon source
b e.g. ampicil l in, tetracycline, kanamycin, chloramphenicol
c e.g. aromatic compounds, solvents, halogens, heavy metals, hydrocarbons, alcohols
1 recombinant protein production
2 bioremediation
3 biosensors
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2.2.3.1 Bacillus subtilis  
Bacillus subtilis is the best characterized and the most widely exploited host of Gram-
positive bacteria (Dubnau 1982). The bacterium is both utilized as a model host for 
fundamental research and a work horse in biotechnological processes. Due to its 
superior bioprocess characteristics, that is, the lack of toxic byproducts, high production 
yields (up to 20-25 g/l), and the facility for efficient secretion of the products, B. subtilis 
has been broadly utilized in the production of recombinant proteins, antibiotics, and 
vitamins (Hao et al. 2013; van Dijl and Hecker 2013).  
Being a facultative aerobe and a biofilm and spore-forming bacterium, B. subtilis can 
resist harsh environmental stress and nutrient deprivation for long periods. Moreover, 
the bacteria possess a complex motility and chemotaxis system. The bacteria can also 
produce a variety of secondary metabolites including fungal and bacterial inhibitors, 
providing a competitive advantage in natural environments (Stein 2005). B. subtilis can 
utilize a variety of carbohydrates and peptides as a carbon source and is capable of 
nitrate assimilation. The widely used laboratory strain B. subtilis 168 is auxotrophic for 
tryptophan. 
B. subtilis 168 has been long exploited in molecular genetic, proteomic and biofilm 
studies (Lemon et al. 2008; Becher et al. 2011; Commichau et al. 2013). The genome 
of the strain was sequenced in 1997 (Kunst et al. 1997), followed by a construction and 
more recently enhanced metabolic model (Henry et al. 2009). In addition, a 
comprehensive database for B. subtilis genomic and metabolic information has been 
recently established (Michna et al. 2014).  
The laboratory strain can be induced for natural competence (Hamoen et al. 2003), 
which promotes genetic engineering. Genome engineering tools (Kumpfmuller et al. 
2013) and expression vectors (Nguyen et al. 2005), some being BioBrick compatible 
(Radeck et al. 2013), are widely available for the strain. Furthermore, a genome 
reduction approach has been applied to B. subtilis to increase the host robustness 
(Westers et al. 2003; Ara et al. 2007); subsequently it was also demonstrated that 
streamlining the genome resulted in improved biomass and protein productivity 
(Morimoto et al. 2008; Manabe et al. 2011). Recently, Tanaka et al. determined 
nonessential regions in the B. subtilis 168 genome by successfully deleting 146 
individual regions covering ~76 % of the genome (Tanaka et al. 2013) and information 
was exploited in further improvement of the model predictions regarding the cell 
viability. These studies demonstrate the potentiality of the strain for synthetic biology 
applications and pave the way for a minimal B. subtilis cell factory.  
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2.2.3.2 Pseudomonas putida 
The genus Pseudomonas comprises a vast number of Gram-negative, aerobic 
bacterial species involving both pathogenic and non-pathogenic strains (Palleroni 
2010). Common characteristics include the ability to adapt to different nutritional and 
physicochemical environments, the capability to survive stress, and the ability to 
synthesize bioactive compounds (Silby et al. 2011). The laboratory strain P. putida is a 
non-pathogenic soil bacterium possessing broad catabolic diversity for the utilization of 
various aliphatic, aromatic, and heterocyclic compounds, organic acids, alcohols and 
other complex hydrocarbons as carbon sources (Jimenez et al. 2002).  
P. putida has been widely exploited as a model bacterium in fundamental studies 
regarding environmental bacteria. The potential of the strain to efficiently degrade and 
convert toxic organic wastes and petroleum-based compounds to harmless or value-
added compounds has led to extensive studies and bioremediation applications in the 
field of environmental biotechnology (Poblete-Castro et al. 2012).   
Apart from being exploited in bioremediation and biocatalysis applications, P. putida 
has potential for the production of industrially relevant compounds. The strain naturally 
produces polyhydroalkanoate (PHA), biocompatible and biodegradable polymer 
exploited in biomaterial industries and tissue engineering (Tripathi et al. 2013). 
Moreover, Pseudomonas strains have been broadly exploited in de novo synthesis and 
bioconversion of chiralic compounds and other important chemicals (Poblete-Castro et 
al. 2012).  
The metabolic characteristics of P. putida promote its use in industrial scale processes; 
simple growth requirements, the versatile carbon metabolism, and efficient machinery 
for product tolerance and cofactor regeneration rate serve as a base for a promising 
cell factory for various applications. Moreover, P. putida KT2440 genome sequence 
(Nelson et al. 2002) and construction of a metabolic model (Nogales et al. 2008) have 
promoted the strain usability in biotechnology. For example, high butanol tolerance 
(Ruhl et al. 2009) and recombinant expression of alcohol producing genes from C. 
acetobutylicum have enabled the production of butanol in titres 120 mg/l (Nielsen et al. 
2009). Also, the substrate range has been further extended for the utilization of 
pentose sugars by metabolic engineering (Meijnen et al. 2008). In general, tools for 
gene and genome engineering in P. putida are sufficiently available (de Lorenzo et al. 
1990; Silva-Rocha et al. 2013). Genome streamlining, i.e. the removal of unnecessary 
parts of the chromosome, have been also applied to P. putida (Leprince et al. 2012a). 
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Recently, the P. putida strain has been increasingly brought up in the context of 
synthetic biology (Nikel et al. 2014). For example, in a previous study the TOL toluene 
degradation pathway of Pseudomonas was exploited in constructing a multicellular 
logic gate based on cell-cell communication and metabolic wiring (Silva-Rocha and de 
Lorenzo 2014). In the system, toluene served as in input for a sender strain converting 
the compound to benzoate, the output molecule. Benzoate was sensed by a receiver 
cell which responded to this input by producing visible light as a measurable output 
signal. 
2.2.3.3 Acinetobacter baylyi ADP1 
Acinetobacter baylyi ADP1 (here: ADP1), previously referred as BD413, is a Gram-
negative, non-motile, strictly aerobic laboratory strain. The strain was derived from a 
heavily encapsulated ubiquitous soil bacterium Acinetobacter baylyi BD4 by a single-
step mutation (Taylor and Juni 1961; Barbe et al. 2004). Acinetobacter spp. typically 
produce extracellular polysaccharides (EPS) to form a protecting capsule and to 
facilitate substrate uptake, but in contrast to BD4, the derived strain ADP1 possesses 
only a “mini-capsule” (Kaplan and Rosenberg 1982). The strain ADP1 is nutritionally 
versatile, possessing catabolic features similar to taxonomically close relatives P. 
aeruginosa and P. putida (Barbe et al. 2004). The strain does not, however, carry any 
virulence or pathogenicity factors.  
The genome of ADP1 consists of one circular chromosome containing 3.6 million base 
pairs with GC-content of 40.3 %. There are 3325 coding sequences of which 3197 are 
annotated as protein coding genes. About 20 % of ADP1 genes are associated to 
catabolic functions. Most of the catabolism related genes are organized in five clusters 
or ‘catabolic islands’, with operons tens of thousands base pairs long. (Young et al. 
2005) The genome possessing the exceptional orientation of genes serves as a highly 
convenient platform for genome editing. The strain ADP1 is closely related to E. coli, 
allowing the integration of existing knowledge about the genetics and metabolism. 
ADP1 exhibits most of the beneficial features of E. coli but there are also relevant 
differences that promote ADP1 as a potential host for synthetic biology. 
Acinetobacter strains are frequently found in a variety of growth environments with 
quickly changing conditions. This can be seen in the strain characteristics regarding 
catabolic diversity, wide growth temperature range, efficient substrate utilization, 
tolerance to toxic compounds, and production of storage compounds, such as 
cyanophycin granule peptide (CGP), triacylglycerols (TAG), and wax esters (WE) 
(Kalscheuer and Steinbüchel 2003; Elbahloul et al. 2005).  
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Acinetobacter strains efficiently utilize a wide range of polar and non-polar 
hydrocarbons such as aliphatic alcohols, carbohydrates, long-chain fatty acids, glycols 
and polyols, aromatic and halogenated compounds, amino acids, alkanes, and small 
organic acids as a sole carbon and energy source. A. baylyi strains lack the gene for 
pyruvate kinase, as well as for glucokinase, hexokinase and a glucose transporter 
phosphotransferase system (PTS), which are important enzymes in a carbohydrate 
metabolism (Barbe et al. 2004). Therefore ADP1 cannot directly phosphorylate 
glucose, and a glucose molecule is oxidized to gluconate on the outer surface of the 
inner membrane by an electron carrier associated to glucose dehydrogenase, 
pyrroloquinoline quinine (PQQ). Notably, due to exceptional glucose metabolism 
following a modified Entner-Duodoroff pathway (Entner and Doudoroff 1952), ADP1 
grows generally better on carbon sources that enter the main metabolic pathways 
through citric acid cycle (such as acetic acid) than on carbon sources that are 
processed in glycolysis (Barbe et al. 2004; Young et al. 2005).  
To briefly mention other important catabolic pathways, the degradation of aromatic 
compounds is mediated by the multistep β–ketoadipate pathway, similar to 
pseudomonads (Young et al. 2005; Williams and Kay 2008). Nine essential enzymes 
are involved in the conversion of aromatic compounds to protocatechuate, and further 
to β-ketoadiapate, and finally TCA cycle intermediates (Ornston 1966). Also, the 
utilization of alkanes is a wide spread trait among Acinetobacter species. In ADP1, the 
degradation is dependent on several genes including constitutively transcribed rubAB 
and xcpR. The terminal alkane hydroxylase alkM and the regulator alkR are inducible 
and found to be essential when grown on alkanes (Geissdorfer et al. 1995; Ratajczak 
et al. 1998; Ishige et al. 2000).  
With regard to valuable biocompounds, the most interesting pathways of ADP1 involve 
the synthesis of fatty acid (FA) derived long chain hydrocarbons, WEs and TAGs 
(Figure 2.10). TAGs are non-polar and hydrophobic glycerol triesters with three FAs, 
whereas WEs are oxoesters of long-chain primary fatty alcohols and long-chain FAs. 
Both molecules serve primarily as carbon storages and are mobilized under carbon 
limiting conditions, but they can also function against dehydration (Wältermann and 
Steinbüchel 2005). 
The key step in TAG synthesis is the esterification of a long chain FA with a 
diacylglycerol molecule, a common precursor to bacterial phospholipid synthesis. The 
esterification is carried out by a membrane-bound bifunctional wax ester synthase/acyl-
CoA:diacylglycerol acyltransferase enzyme WS/DGAT (atfA, ACIAD0832) (Kalscheuer 
and Steinbüchel 2003). TAGs are mainly produced in a stationary growth phase under 
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nitrogen limiting conditions, and they stored as intracellular lipid inclusions 
(Wältermann et al. 2005).  
Wax esters possess more dynamic nature compared to TAGs (Fixter et al. 1986) and 
they can occur as intracellular inclusions of various shapes (Ishige et al. 2002). In the 
natural WE synthesis pathway of ADP1, a NADPH dependent fatty acyl-CoA reductase 
Acr1 (Reiser and Somerville 1997) converts a fatty-acyl CoA molecule to a 
corresponding fatty aldehyde, followed by a conversion of fatty aldehyde to fatty 
alcohol by a yet uncharacterized alcohol dehydrogenase/aldehyde reductase(s). In the 
final step, the fatty alcohol molecule is esterified with a fatty acyl-CoA molecule by the 
well-characterized bifunctional enzyme WS/DGAT, resulting in the formation of a wax 
ester molecule. The natural WEs in ADP1 predominantly consist of monounsaturated 
C16 or C18 carbon chains when the cells are grown on glucose. However, the 
utilization of alkanes or alkanols as a substrate results in a significant accumulation of 
WEs (Ishige et al. 2002), and the alkyl chain lengths are determined by the used 
substrate.  
 
FIGURE 2.10. The biosynthetic pathways related to neutral lipid production of A. baylyi 
ADP1. 
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Another interesting biomolecule produced by Acinetobacter strains is cyanophycin 
granule peptide (CGP). The molecule is a branched polypeptide consisting of aspartate 
backbone and arginine residues exploitable e.g. in polyacrylics synthesis. The natural 
production of CGP is triggered by a phosphate starvation and excess provision of 
arginine (Elbahloul et al. 2005), and the synthesis is catalyzed by cyanophycin 
synthetase (CphA) (Krehenbrink et al. 2002). The enhanced production of CGP has 
been demonstrated in engineered ADP1 (Elbahloul and Steinbüchel 2006); the deletion 
of the arginine regulatory protein (argR) and the arginine succinyltransferase (astA), or 
the overexpression of phoB of phosphate regulon system increased the CGP 
production by up to 8.6 fold. 
The most impressive work done with ADP1 thus far constitutes a comprehensive 
analysis on ADP1 genome, transcriptome, and metabolome levels. The multiomics 
approach has involved the construction of a metabolic model (Durot et al. 2008) 
encompassing 875 reactions, 701 distinct metabolites, and 774 genes. In addition, a 
complete collection of a single gene knock-out mutant library was constructed (de 
Berardinis et al. 2008), followed by the experimental annotation of genes (Genoscope 
2009). Recently, an extensive analysis of ADP1 transcriptome and metabolome levels 
in response to different perturbations was carried out (Stuani et al. 2014). 
Most interestingly, the strain ADP1 is naturally transformable (Palmen and Hellingwerf 
1997), enabling straight-forward gene and genome engineering. Transformable 
Acinetobacter strains do not discriminate between homologous and heterologous DNA 
or display any sequence specificity at the stage of binding and uptake. Linear and 
plasmid DNA are brought into the cells by the same uptake system, followed by DNA 
incorporation to the chromosome by homologous recombination, or plasmid 
recircularization (Palmen et al. 1993). Thus single or multiple gene deletions and 
insertions using synthetic gene fragments or gene cassettes can be carried out in a 
high-throughput manner using an automated system (Figure 2.11). However, 
compared to for example the widely exploited λ red recombinase –mediated 
chromosomal incorporation and replacement (Datsenko and Wanner 2000), the 
recombination machinery of ADP1 requires relatively long homologous sequences 
(optimally >500 bp (Simpson et al. 2007)) for the genome target site, thus slightly 
complicating the construction of the genome engineering tools. In addition, relatively 
large amounts of DNA are required for transformations at sufficient rate. Therefore, 
increasing the efficiency of natural transformation and homologous recombination 
represent one important engineering target in developing the strain ADP1 as a chassis. 
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FIGURE 2.11. The method for a site-specific gene knock-out in A. baylyi ADP1 using a 
synthetic gene cassette. 
To further facilitate the use of ADP1 in metabolic engineering and synthetic biology, 
efficiently replicating expression vectors for the strain have been recently described 
(Bryksin and Matsumura 2010; Murin et al. 2012). The vectors are also compatible with 
the BioBrickTM standard. The study by Murin et al. also demonstrates that the 
commonly used promoters, such as T5, T7, and BAD, are functional in ADP1. 
Despite the attractive characteristics of ADP1 and the recently increased use as a 
model strain in fundamental genomic and metabolic studies (Metzgar et al. 2004; de 
Berardinis et al. 2009; Elliott and Neidle 2011; Zhang et al. 2012b), only a few true 
application platforms have been introduced, apart from exploiting the individual 
enzymes of ADP1 (see Chapter 3; (Stöveken and Steinbüchel 2008)). Table 2.2 
presents some described approaches to exploit Acinetobacter strains in biotechnology. 
Due to the versatile catabolic machinery of ADP1, the field is largely focused on 
biosensor and bioremediation applications in environmental bioengineering. However, 
industrially relevant biomolecules such as bioemulsifiers, lipases, and CGP that are 
naturally produced by Acinetobacter strains have also drawn interest. As P. putida, 
ADP1 holds potential for whole-cell biocatalysis and bioconversion processes. 
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TABLE 2.2. Examples of Acinetobacter based applications. 
Application or Product Field Strain Engineering Reference 
Detection of contaminants and Environmental biotech. ADP1 Expression of lux operon  (Zhang et al. 2012a) 
xenobiotics from soil and water / Bioremediation   under specific promoter (Abd-El-Haleem et al. 2006) 
environments by whole cell     
 
(Abd-El-Haleem et al. 2002) 
biosensors    
 
(Wang et al. 2014b) 
     
Cyanophycin Biotechnology   Inactivation of argR, astA, (Elbahloul and Steinbüchel 2006) 
 
   overexpression of phoB   
Crude oil removal from soil Bioremediation A3  (Hanson et al. 1997) 
Bioemulsan Biotechnology RAG-1 
 
(Shabtai 1990; Shabtai and Wang 1990) 
  (Several)  (Gutnick et al. 1989) 
Modified emulsan    Protein engineering (Dams-Kozlowska and Kaplan 2007) 
Modified emulsan    Transposon mutations (Johri et al. 2002) 
Bio-Pd catalysts    
 
(Baldi et al. 2011) 
Emulsan / adjuvant Biomedicine   
 
(Panilaitis et al. 2002) 
Wax esters Biotechnology M-1 
 
(Ishige et al. 2002) 
 
   
 
  
Lipases Biotechnology (Several)   (Snellman and Colwell 2004) 
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3 Synthetic biology for sustainable bioenergy 
In the times of consistently growing energy demand and increasing insecurity related to 
fossil fuels supply and environmental concerns, synthetic biology aims at fighting the 
challenges with novel microbial platforms for sustainable bioenergy production. 
Transportation fuels comprise a major share of the consumed energy, and biologically 
produced advanced biofuels are suggested to replace the fossil counterparts and food-
crop based first generation biofuels. The synthetic biology approach enables the 
production of customized drop-in liquid fuels with defined characteristics, not restricted 
to the properties of natural products. Despite the existing and optimized processes for 
bioethanol production, advanced biofuels (i.e. long chain (C≥4) alcohols, alkanes, FA 
alkyl esters, terpenes) have drawn a lot of attention due to their incomparable 
properties, higher energy content, and compatibility with existing engine systems and 
infrastructure. 
Atmospheric carbon dioxide and solar energy are stored in different forms of biomass. 
Microbes have the capability to convert the biomass into high-energy compounds 
exploitable in biofuels. Metabolic engineering and synthetic biology focus on enhancing 
the production systems to be more robust in terms of product quality, quantity, and 
sustainability. Optimally, custom-made fuel components compatible with the existing 
infrastructure could be produced from cheap and sustainable non-food substrates, 
such as agricultural or forest waste, or energy crops (Figure 3.1). In addition to 
constructing the actual metabolic pathways in cells, novel strategies for improved 
product titers involve a comprehensive omics –level analyses and sensor systems. The 
strategies promote the identification of the bottle necks, the alleviation of product 
toxicity, and the construction of protein scaffolds to facilitate optimal metabolic fluxes.  
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FIGURE 3.1. Sustainable production of advanced biofuels by the bacterium E. coli. 
Modified from (Peralta-Yahya et al. 2012) and (Kung et al. 2012) 
Despite the significant improvements achieved with the new strategies for redesigning 
and engineering cell factories, there are still unsolved issues related to process scale-
up and economy, insufficient product titers, the inhibitory effects of products and 
intermediates, the efficient utilization of cellulosic substrates, and constraints set by cell 
metabolism. In the following section, some of the major advances in the field of 
engineered bacterial production of advanced biofuels are described. Although the focus 
is on prokaryotic systems, it is noteworthy that several eukaryotic microbes, such as 
oleaginous yeasts Yarrowia lipolytica and Cryptococcus spp. (Beopoulos et al. 2009; 
Ageitos et al. 2011), and metabolically engineered S. cerevisiae (Runguphan and 
Keasling 2014; Zhou et al. 2014), represent important hosts in the production of 
bioenergy molecules.  
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3.1 Production of advanced biofuels 
3.1.1 Alcohols 
For short and medium-chain alcohol production, either fermentative or non-
fermentative pathways can be exploited. In a typical approach, acetyl-CoA dependent 
fermentative pathways (Figure 3.2) employing enzyme activities from Clostridium 
species have been used to produce isopropanol (Hanai et al. 2007; Inokuma et al. 
2010) and 1-butanol (Atsumi et al. 2008a) in an engineered E. coli. The titers for 1-
butanol have been further enhanced by metabolic engineering, applying several gene 
knock-outs for eliminating competitive pathways (Atsumi et al. 2008a) and further 
pathway optimization by replacing individual enzymes (Bond-Watts et al. 2011). By 
these approaches, titers up to 4.65 g/l have been achieved (Bond-Watts et al. 2011). 
Other reported recombinant prokaryotic hosts for the production of 1-butanol include P. 
putida and B. subtilis (Nielsen et al. 2009), justified by better product tolerance 
compared to E. coli. Photosynthetic carbon fixing cyanobacteria have been also 
employed (Machado and Atsumi 2012). Recently, a synthetic pathway for butanol 
production with improved oxygen tolerance was established by employing an acyl 
carrier protein (ACP) dependent pathway instead of the acyl-CoA dependent 
fermentative pathway; the expression of a thioesterase from Bacteroides fragilis and an 
aldehyde reductase ahr from E. coli resulted in a butanol titer of ∼300 mg/l (Pasztor et 
al. 2014).  
3 SYNTHETIC BIOLOGY FOR SUSTAINABLE BIOENERGY 
 
33 
 
 
FIGURE 3.2.A schematic overview of possible fermentative pathways for alcohol 
production. The pathways include reactions from both autotrophic and 
heterotrophic organisms. Modified from (Lamsen and Atsumi 2012).  
In 2008, Atsumi et al. introduced a synthetic non-fermentative pathway for the 
production of branched higher alcohols such as isobutanol and 2-methyl-1-butanol. 
Only traces of these compounds are naturally produced by bacteria. The pathway is 
taking advantage of the NADPH dependent amino acid biosynthesis pathway 
producing 2-ketoacids, which are further converted to alcohols through decarboxylation 
and reduction reactions by 2-keto acid decarboxylase KDC (e.g. kivD gene from 
Lactococcus lactis) and an alcohol dehydrogenase (e.g. ADH2 from S. cerevisiae), 
respectively (Atsumi et al. 2008b) (Figure 3.3). The pathway can be readily expressed 
in a variety of hosts, and toxic intermediates are not produced. A substantial number of 
studies exploiting the ketoacid pathway for the production of alcohols, chemicals, and 
other biocompounds have been reported (Jambunathan and Zhang 2014).  
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FIGURE 3.3.The aminoacid biosynthesis related ketoacid pathway for non-fermentative 
production of aliphatic and branched alcohols. KDC - 2-keto acid 
decarboxylase, ADH – Alcohol dehydrogenase. Modified from (Jambunathan 
and Zhang 2014). 
Another approach to produce higher alcohols is to exploit reverse fatty acid β-oxidation 
pathway, normally assigned for the degradation of acyl-CoAs in aerobic conditions. In 
semi-aerobic and anaerobic conditions with artificially regulated β-oxidation and alcohol 
producing pathway genes it has been possible to produce 1-butanol and longer n-
alcohols (Dellomonaco et al. 2011; Clomburg et al. 2012; Gulevich et al. 2012). 
3.1.2 Isoprenoid fuels 
To briefly introduce promising new candidates for advanced biofuel production, 
isoprenoids, i.e. terpenes are a functionally and structurally diverse group of 
hydrocarbons, typically serving as relevant precursors for medical industries. Some 
isoprenoid products, such as pinene and farnesene, can be potentially used as 
gasoline, diesel, or jet fuel. Isoprenoids are produced by an acetyl-CoA originated 
mevalonate (MEV) pathway or by a 1-deoxy-D-xylulose-5-phosphate (DXP) pathway 
beginning with glyceraldehyde-3-phosphate and pyruvate, resulting in universal 
precursors isopentenyl pyrophosphate (IPP) and dimethylallyl pyrophosphate 
(DMAPP), respectively. These molecules can be further processed by classes of 
terpene synthases and cyclases to form a variety of mono- or polycyclic or aliphatic 
compounds. Farnesene and saturated farnesane have been produced in engineered E. 
coli from farnesyl pyrophosphate intermediate by introducing a codon optimized β-
farnesene synthase from Artemisia annua. The production process was scaled up by 
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Amyris Biotechnologies, Inc. for the mass production of farnesene as a fuel additive. 
(Renninger and McPhee 2008) 
3.1.3 Fatty acid derived compounds 
Fatty acids (FA) have high energy content and properties convenient for fuel purposes, 
but due to their ionic nature they cannot be directly exploited as biofuels. Fatty acids 
and ac(et)yl-CoAs are however important precursors for several interesting molecules, 
such as FA alkyl esters, alkanes, fatty alcohols, and triacylglycerols (TAG). Fatty acid 
and acyl-CoA synthesis pathways have been extensively studied and engineered, 
especially in E. coli, to facilitate the production of advanced biofuels (Handke et al. 
2011; Lennen and Pfleger 2012; Xu et al. 2013).   
TAGs constitute of three fatty acids esterified with a glycerol backbone, and they are 
considered as an appropriate feedstock for a biodiesel synthesis process. Even though 
the TAG molecules are not directly exploitable as drop-in in liquid fuels, they are 
compatible with existing production processes and infrastructure; TAGs can be derived 
to a mixture of esters constituting of long chain fatty acids and short chain alcohols, 
namely fatty acid alkyl esters, such as FA methyl esters (FAME) or ethyl esters (FAEE) 
suitable for traffic fuel. TAGs are neutral lipids and natural carbon and energy storages 
in animals, plants and in a number of bacteria such as Streptomyces, Nocardia, 
Acinetobacter, and Rhodococcus species (Alvarez and Steinbüchel 2002). 
Rhodococcus opacus cells, for example, can naturally accumulate up to 80 % TAG of 
cell dry weight in nitrogen limiting conditions (Alvarez et al. 1996). In a study of 
Kurosawa et al. (2010), a titer of 77.6 g/l TAGs could be obtained in a batch bioprocess 
of R. opacus containing high glucose concentration and critical C/N ratio of 17.8 
(Kurosawa et al. 2010). More recently, the same group demonstrated a more 
sustainable approach to TAG production with R. opacus engineered with Streptomyces 
DNA library for using high concentrations of xylose as a substrate (Kurosawa et al. 
2013).  
In a synthetic biology point of view, more readily engineered cell systems enable 
broader substrate and product range and regulated production, and thus serve as a 
more convenient approach for biodiesel production. The emphasis has been on the 
direct production of drop-in FA based fuels, for example FAEEs, exploiting the newly 
described acyl-coenzyme A, diacylglycerol acyltransferase WS/DGAT (atfA) from A. 
baylyi ADP1 (Kalscheuer and Steinbüchel 2003; Kalscheuer et al. 2004; Kalscheuer et 
al. 2006a). Fatty acid synthesis is strongly regulated, feedback inhibited, and 
dependent on acetyl-CoA supply, for which the engineering of the production of FA 
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based compounds is challenging. The earliest example of direct production of FAEEs 
(Kalscheuer et al. 2006a) in E. coli was achieved by the external supply of fatty acid 
substrate, followed by a pilot-scale production of FAEEs in an optimized bioprocess 
(Elbahloul and Steinbuchel 2010). In the study of Steen et al. (2010) no substrate 
addition was required; an improved carbon flux towards FA and acyl-CoA syntheses 
and eventually FAEE production was obtained by metabolic engineering. The 
modifications included the overexpression of modified cytosolic thioesterase ’TesA 
lacking the leader sequence for periplasmic expression, the elimination of the β-
oxidation cycle by fadE deletion, and overexpression of acyl-CoA ligases and fadD, 
facilitating the activation of FFAs to acyl-CoA. For FFAs, titers of 1.2 g/l could be 
obtained (Steen et al. 2010). Production of the alcohol counterpart (ethanol) was 
established by expression of pyruvate decarboxylase pdc and alcohol dehydrogenase 
adhB from Zymomonas mobilis. In the final step of the in vivo esterification of fatty acyl-
CoA and short chain alcohol, the above mentioned bifunctional and highly unspecific 
acyltransferase WS/DGAT was exploited, eventually resulting in titer of 674 mg/l 
FAEEs. In addition, the expression of an endoxylanase catalytic domain (Xyn10B) from 
Clostridium stercorarium and a xylanase (Xsa) from Bacteroides ovatus enabled a 
consolidated process of utilization of hemicellulosic substrate and production of biofuel. 
In the next step, the production of biofuel components directly from switch grass was 
demonstrated (Bokinsky et al. 2011). Shortly after, the FAEE titer could be increased to 
1.5 g/l with a sophisticated regulator/sensor system (see Chapter 3.2) responsive to FA 
and acyl-CoA levels in the cell (Zhang et al. 2012c). In the study by Choi and Lee 
(2013), FAEEs were produced by expressing a mutated alcohol dehydrogenase (adhE) 
from E. coli and the wax ester synthase WS/DGAT from ADP1, resulting in the titer of 
480 mg/l C10-C14 FAEEs. 
Fatty aldehydes, fatty alcohols, and wax esters are products of different stages of a 
single pathway derived from FAs (Figure 3.4). These long chain hydrocarbons are 
considered as high-value molecules (appr. 1500 $/t) exploited mainly in fine chemical, 
cosmetics, medicine, and food industries. Due to their properties, they are also 
convenient for bioenergy production. Fatty aldehydes and alcohols are produced from 
FA or fatty acyl-CoA/ACP substrates through reduction reactions by fatty acid/aldehyde 
reductases (FAR) (Table 3.1). Fatty alcohols with variable chain lengths have been 
produced in heterologous E. coli by altering the thioesterases used, i.e. BTE from 
Umbellularia californica or ‘TesA from E. coli, and the reductase counterpart, a 
bifunctional FA-CoA reductase from Simmondsia chinensis or Acr1 from A. baylyi 
ADP1, leading to an alternative synthesis of C12/14 or C16/18 fatty alcohols (Zheng et 
al. 2012b). More recently, significant amounts of C12-18 alcohols (1.725 g/l) were 
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produced in a fermentation process of engineered E. coli expressing a bifunctional 
acyl-CoA/aldehyde reductase from Marinobacter aquaeolei VT8 together with modified 
tesA and fadD genes (Liu et al. 2013), whereas high yields of C12-C14 alcohols (0.13 
g/g glucose with a titer 1.6 g/l) were produced in a study exploiting an acyl-ACP 
thioesterase (BTE), FadD, and the same M. aquaeolei reductase in an engineered E. 
coli (Youngquist et al. 2013). Improved yields could be obtained by gene expression 
level balancing and optimized fed-batch cultivation. The photosynthetic fatty alcohol 
production was enhanced in metabolically engineered cyanobacteria by introducing the 
fatty acyl-CoA reductase from M. aquaeolei VT8 combined with knock-outs of an acyl-
ACP reductase and an aldehyde-deformylating oxygenase genes (Yao et al. 2014).  
 
FIGURE 3.4. Biochemical pathways for the production of fatty acid derived compounds. 
The key enzymatic steps are numbered, and examples of enzymes are 
provided. FAEE – Fatty acid ethyl ester (biodiesel), FAAE – Fatty acid alkyl 
ester (wax ester).  
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Modified esters consisting of diverse fatty acid and alcohol (>C2) moieties can be 
produced in recombinant hosts. Conventionally, alkyl esters are chemically produced in 
harsh conditions by Fisher esterification using fossil feedstock, and thus an alternative 
biological production process is of high relevance. Guo et al. (2014) described an 
approach of combining a 2-keto acid pathway and an engineered FA synthesis 
pathway for the optimized production of a variety of branched and aliphatic FA short-
chain esters using glycerol as a substrate (Guo et al. 2014). Layton and Trinh (2014) 
introduced a modular platform for the anaerobic fermentative production of variable 
butyrate esters in engineered E. coli, involving knockouts to block e.g. the competitive 
fermentative pathways, and insertions of designed individual submodules for the 
production of acyl-CoAs, alcohols, and an alcohol acyltransferase (Layton and Trinh 
2014). In contrast, Rodriguez et al. (2014) constructed several aerobic acetate ester 
pathways in E. coli based on the esterification of acetyl-CoA with branched alcohols 
produced by the keto acid pathway. A remarkable titer of 17.2 g/l for isobutyl acetate 
from glucose was achieved, being 80 % of the theoretical yield (Rodriguez et al. 2014). 
In the same study, a fatty acid reductase complex LuxCDE from Vibrio harveyi was 
exploited for production long-chain tetradecyl-acetate. 
Among bacteria, wax esters (WE) are natural products e.g. of Marinobacter (Lenneman 
et al. 2013) and Acinetobacter (see Chapter 2.2.3.3) strains. For the recombinant 
production of WEs, an expression of FAR from S. chinesis and WS/DGAT from ADP1, 
with the supplementation of fatty alcohol substrate, have enabled the production of 
jojoba-like WEs in E. coli (Kalscheuer et al. 2006b). Steen et al. (2010) established the 
WE synthesis in recombinant E. coli without inclusion of external alcohols by a 
simultaneous expression of exogenous FAR, an endogenous alcohol dehydrogenase, 
and WS/DGAT. More recently, Kaiser et al. (2013) demonstrated the production of 
WEs in cyanobacteria by co-expression of the native acyl-ACP reductase, a long-chain 
alcohol dehydrogenase from Synechocystis sp PCC 6803 (slr1192), and WS/DGAT. 
However, for an unknown reason, the formed neutral lipid inclusions were found to be 
toxic to the Synechocystis cells.  
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TABLE 3.1. Some key reductases exploited in a recombinant production of fatty aldehydes, 
fatty alcohols, esters and alka(/e)nes. 
Enzyme Gene Strain of origin 
Preferred  
substrates Reference 
Fatty acyl-CoA 
reductase acr1 
Acinetobacter 
baylyi ADP1 
acyl-CoA;  
C16-18 (Steen et al. 2010) 
     
Fatty acyl-CoA 
reductase Maqu_2220 
Marinobacter 
aquaeolei VT8 
acyl-CoA; 
C12-18 
(Liu et al. 2013; Yao et al. 
2014) 
     
Carboxylic acid 
reductase 
 
Mycobacterium  
marinum FA; C6-18 (Akhtar et al. 2013) 
     
Fatty acyl-CoA 
reductase 
 
Simmondsia  
chinensis  acyl-Coa; C20- (Zheng et al. 2012b) 
     
Acyl-ACP reductase, 
AAR 
PCC7942_orf1
594 
Synechococcus  
elongates 
acyl-ACP;  
C14-18 
(Schirmer et al. 2010; 
Kaiser et al. 2013) 
     
FAR complex,  
LuxCDE luxCDE 
Photorhabdus  
luminescens 
FA (-CoA, -
ACP); C10-18 (Howard et al. 2013) 
     
FAR complex, 
LuxCDE luxCDE Vibrio harveyi 
FA (-CoA, -
ACP); C10-18 (Rodriguez et al. 2014) 
     
fatty acyl-CoA  
reductase acr 
Clostridium  
acetobutylicum  acyl-CoA; C8-14 (Choi and Lee 2013) 
     
Fatty acyl-CoA  
reductase, Cer4  
Arabidopsis  
thaliana acyl-CoA (Zheng et al. 2012b) 
Alkanes and alkenes are aliphatic hydrocarbons which are products of a different 
branch of the above described FA derived pathway typically employing fatty aldehydes 
as the key precursors. Alkanes can be directly exploited as the constituents of gasoline 
and jet fuel. Several approaches to microbial alkane production have been described. 
Schirmer et al. described the microbial production of alkanes by engineered E. coli 
exploiting the alkane synthesis pathway from cyanobacteria. The pathway consists of 
an acyl-ACP reductase and an aldehyde-deformylating oxygenase (ADO), which 
convert the intermediates from FA synthesis to alkanes and alkenes, the carbon chain 
profile ranging from C13 to C17 (Schirmer et al. 2010).  
In another study (Choi and Lee 2013) shorter chain ‘gasoline’ alkanes (C9-C14) were 
produced exploiting a similar pathway involving E. coli fatty acyl-CoA synthetase, 
Clostridium acetobutylicum fatty acyl-CoA reductase and Arabidopsis thaliana fatty 
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aldehyde decarbonylase. The titers were further improved employing metabolic 
engineering approach; β-oxidation pathway was blocked by deleting the fadE gene to 
increase the supply of fatty acyl-CoA substrates to hydrocarbon synthesis. Also, fadR 
was deleted in order to boost up the synthesis of suitable FAs and to hinder the 
synthesis of unsaturated FAs. To generate FFAs from acyl-ACPs for alkane synthesis, 
a modified thioesterase was used. A total titer of 580.0 mg/l alkanes could be 
produced.  
Very recently, a platform for the production of renewable short-chain alkane, i.e. 
propane, using a synthetic metabolic pathway was established in recombinant E. coli. 
The pathway employed a butyryl-ACP specific thioesterase and was complemented 
with an electron-donating module and elimination of endogenous aldehyde reductases 
(Kallio et al. 2014).  
For long chain alkene production, a three-gene cluster from Micrococcus luteus was 
introduced to FA overproducing E. coli strain, resulting in production of C27:3 and 
C29:3 alkenes (Beller et al. 2010). In a study by Akhtar et al, the expression of a wide 
substrate range carboxylic acid reductase (CAR) from Mycobacterium marinum and an 
aldehyde reductase, or alternatively an aldehyde decarbonylase resulted in production 
of C8-18 fatty alcohols and C7-15 alkanes, respectively (Akhtar et al. 2013).  
A reconstructed pathway for alkane production exploiting FA reductase complex 
LuxCDE from Photorhabdus luminescens and an aldehyde decarbonylase from Nostoc 
punctiforme was established, resulting in production of alkanes with rationally altered 
chain lengths (Howard et al. 2013). Further genetic manipulation of the FA substrate 
pool enabled the production of custom-made branched alkanes. 
3.2 Dynamic monitoring tools for enhanced bioproduction 
The activity of genes and individual enzymes are affected by several factors inside the 
cells, resulting in an extremely delicate system in terms of expression levels and 
productivity. Maximal expression guarantees no maximal productivity; the 
overproduction of enzymes consumes cellular building blocks and energy, and can be 
toxic to cells. Thus, optimal distribution of cellular resources and cofactors, and a 
dynamic response to fluctuations in internal and external stages are required to tune 
the production systems. Intracellular sensor devices facilitate the screening of optimal 
genotypes and conditions, and identification of potential pathway bottle-necks. Even 
more sophisticated integrated sensory-regulatory devices serve as dynamic tools for a 
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concurrent sensing of the cellular state and responsive regulation of key element 
expression, resulting in balanced metabolism and consequently improved production 
yields and titers. 
Monitoring tools can function either at transcriptional, translational, or at post-
translational levels (Figure 3.5). Sensors functioning at a transcriptional level typically 
comprise a promoter-transcription factor system responsive to a key metabolite of the 
pathway, regulating the expression of a reporter, such as green fluorescent protein 
(GFP). Artificial RNA elements such as riboswitches consisting of ligand-binding 
aptamer domain and expression platform can specifically regulate transcription or 
translation (Ceres et al. 2013; Wachsmuth et al. 2013; Berens and Suess 2014; Ma et 
al. 2014). Qi et al. described a combinatorial approach to engineer ligand-binding RNA 
fusion molecules that regulate both transcription and translation through allosteric 
regulation of trans-acting nc-RNAs (Qi et al. 2012). 
 
Figure 3.5. Different levels of intracellular monitoring of the product formation exploiting a 
reporter based sensor tool. The characteristic lag time between the occurrence 
of the target molecule and the initiation of signal formation is indicated. The 
approximate response times are adapted from (Olson and Tabor 2012). The 
time required for signal detection is not considered. A) Transcriptional level: the 
target molecule induces DNA transcription followed by protein synthesis and 
signal development. B) Translational level: The target molecule interacts with 
RNA molecule thus regulating the reporter expression and signal development. 
C) Post-translational: The target molecule interacts directly with the reporter 
molecule present in the cell, resulting in instant and dynamic signal production. 
A majority of the described sensor-regulatory systems are based on the regulation of 
key enzyme expression. These approaches suffer from a relatively slow response (up 
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to minutes) and the loss of temporal and dynamical range with respect to rapidly 
changing analyte concentrations, since removing a transcription inducer does not 
instantly remove the reporter signal (Olson and Tabor 2012). Furthermore, maintaining 
a transcription level sensor requires a significant input of cellular resources and 
machinery, such as the synthesis of transcription factors. Translational regulation 
based on RNA elements, on the other hand, is more prone to degradation, and thus 
less stable. Post-translational regulation and monitoring, which occur through enzyme-
enzyme or enzyme-metabolite interactions, can be therefore considered as a more 
dynamic and perceptive approach to manipulating, balancing, and analyzing the 
biosynthetic pathway or interest.  
An early example of an integrated regulatory circuit controlling gene expression in 
response to intracellular metabolic states is the improved lycopene production in E. coli 
(Farmer and Liao 2000). In the study, a global Ntr regulatory system was altered in E. 
coli. The engineered system regulated the expression of two key enzymes in lycopene 
synthesis in response to acetyl phosphate, a precursor to acetate and an indicator 
molecule for excess glycolytic flux, resulting in 18-fold improved lycopene production 
through metabolic balancing.  
In a more recent study briefly mentioned in Chapter 3.1.3, a dynamic sensor-regulator 
system for the improved production of FAEEs in E. coli was described (Zhang et al. 
2012c). The expression of key genes involved in the lipid synthesis was regulated by a 
specific DNA-binding transcription factor FadR sensing fatty acyl-CoAs combined with 
synthetic FadR and IPTG regulated promoters. Due to the balanced metabolism and 
stabilized expression system FAEE titers were significantly improved (1.5 g/l), reaching 
28 % of the theoretical maximum.   
Recently described de novo designed riboregulators called “toehold switches” regulate 
translation through the detection of endogenous cognate RNAs (Green et al. 2014). 
The functional sequences of the switches can be modified according to the target 
RNAs, and thus the switch can serve as an orthogonal and programmable regulator for 
gene expression. In addition, a switch coupled with a reporter can be potentially 
exploited as a sensor to monitor the transcriptome levels of the genes of interest. 
Furthermore, the switches provide wide dynamic range and low cross talk.    
Platforms exhibiting both regulation and monitoring function are still in scarce. Indeed, 
potential mechanisms and tools applicable to such approach have been found in 
nature, but only recently these complex systems have been employed in novel 
contexts. In the following subchapter, as an example of a natural robust tool package, a 
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lux multienzyme complex comprising of unique catalytic and signal producing modules 
is introduced and considered in the light of synthetic biology. 
3.2.1 Lux multienzyme complex 
Bioluminescence is a very convenient tool for sensor applications, due to the high 
specificity and sensitivity and the straight-forward signal determination methods. In 
nature, a taxonomically diverse group of bacteria can produce visible light, i.e. 
bioluminescence. The function of bioluminescence is suggested to be related to 
quorum sensing in dense populations, electron transport, and symbiotic life within the 
organelles of marine organisms (Meighen 1993). The bacterial luciferase (Lux) system 
is a multienzyme complex which has been characterized for several bacteria including 
both terrestrial and marine species, and the most widely studied and the best-
characterized Lux systems  belong to the bacteria of genus Vibrio, Photorhabdus (prev. 
Xenorhabdus), and Photobacterium (Engebrecht et al. 1983). Genes behind the 
multienzyme complex are clustered to form a lux operon, with a typical orientations of 
luxCDABE (Photorhabdus sp.) or luxABCDE, (Vibrio sp.), supported by several other 
related genes including cofactor (FMNH2) generating luxG and regulatory genes 
(Meighen 1994; Gray and Garey 2001; Nijvipakul et al. 2008).  
The reductase enzyme complex consists of an acyl transferase (LuxD), an acyl-protein 
synthetase (LuxE), and a FA reductase (LuxC). In the multistep reaction, LuxD cleaves 
an activated FA from its carrier and transfers the FA for LuxE. The maximal activity of 
the transferase is obtained with tetradecanoyl-ACP and tetradecanoyl-CoA substrates. 
The synthetase LuxE produces an acyl-protein thioester via a fatty acyl-AMP 
intermediate. Subsequently, the thioester is converted to corresponding fatty aldehyde 
by the reductase LuxC. The thioester and fatty aldehyde forming reactions require ATP 
and NADPH, respectively. The bacterial luciferase, consisting of two domains LuxA 
and LuxB, convert the fatty aldehyde to corresponding fatty acid molecule and visible 
light (Figure 3.6). In the reaction, a reduced form of flavin mononucleotide (FMNH2) and 
molecular oxygen form a complex which reacts with the fatty aldehyde, creating a 
slowly decaying intermediate compound. Light emission occurs along with the oxidation 
of FMNH2 and the aldehyde substrate. (Meighen 1991) 
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FIGURE 3.6. A schematic representation of the P. luminescens lux operon, and the 
enzyme reactions and cofactors required for bioluminescence production. 
RCOOH – fatty acid, RCHO – fatty aldehyde. 
A majority of bacterial luciferase applications are related to biomedicine (e.g. tumor 
research) or detection of xenobiotics, heavy metals, or antibiotics in environmental and 
food samples (D'Souza 2001; Galluzzi and Karp 2006; Close et al. 2012). In a typical 
whole-cell biosensor, the lux operon is expressed under an appropriate inducible 
promoter (Immonen and Karp 2007; Virolainen et al. 2008), and the bioluminescence 
production is thus regulated at transcriptional level as a result of defined external 
stimulus.  
As bacterial luciferase produces light specifically through the reaction with an aldehyde 
molecule, the system holds great potential for new metabolic level sensors; the 
mechanism enables highly specific and rapid detection which is not dependent on the 
regulation of transcription or translation. Moreover, the enzymatic reactions serve as 
indicators for intracellular cofactor metabolism. In a study by Falls et al, the P. 
luminescens lux operon was introduced to a complete library of E. coli single gene 
knock-out mutants. It was shown that the expression of a non-native pathway coupled 
with a specific gene deletion results in a rearranged distribution of cellular resources 
and changes in biomass production (Falls et al. 2014). Thus, expressing the Lux 
system can give implications to studying changes in the cellular performance and 
physiological state as a result of genetic modifications. The modularity, the instant and 
linear response to cellular metabolite and cofactor levels, and the long history of 
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consistent research on the lux mechanisms, promote the use of the enzyme complex 
as a valuable and competent tool for developing elaborate and sophisticated systems 
for synthetic biology applications (Reeve et al. 2014). 
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4 Synthetic cocultures 
Coculturing of genetically different strains or species is a rapidly evolving new trend in 
synthetic biology (Brenner et al. 2008; Goers et al. 2014). Cocultures can provide 
several advantages over monocultures by being catabolically more versatile, balancing 
biochemical and physical perturbations, increasing the level of modularity, and 
performing distributed multi-step tasks (Figure 2.12). As a result, more robust 
production systems with improved bioprocess characteristics and stability can be 
developed. 
Mixed populations with natural cooperation mechanisms and fluctuating population 
dynamics have been long exploited in applied microbiology, but such natural systems 
lack the possibility for systematic process control and genetic engineering. In recent 
years, the focus of studies has shifted from naturally evolved and differentiated strains 
(Le Gac et al. 2008) towards more controlled and predictable culture platforms. In the 
synthetic biology approach the principles of rational design and engineering are applied 
on the coculture systems allowing the establishment of defined artificial connections 
and cooperation in the consortia. 
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FIGURE 2.12. Cocultures can promote A) an efficient substrate utilization (Eiteman et al. 
2008; Eiteman et al. 2009), B) a stability and tolerance against 
environmental perturbations and rapidly changing conditions (Briones and 
Raskin 2003; Brenner and Arnold 2011), and C) the performance of 
complex multi-step tasks (Tsai et al. 2010; Regot et al. 2011). 
Coculture approach holds potential for a substantial number of industrial and medical 
applications (Bermudez-Humaran et al. 2011; Brune and Bayer 2012; Shong et al. 
2012; Ortiz-Marquez et al. 2013) and serves as a platform for foundational studies 
regarding population interactions and cell-cell communication (Xavier 2011; Pawelczyk 
et al. 2012; Tanouchi et al. 2012). Computational modeling and genome wide analyses 
of cocultures increase the level of understanding and the predictability of the complex 
interactions (Salimi et al. 2010; Hanly and Henson 2011; Bernstein and Carlson 2012). 
In several studies, coculturing has been shown to improve substrate utilization and 
biomass production, and benefit overall cell performance; in a study by Bernstein et al. 
(2011), a coculture of ‘primary’ glucose-positive and ‘secondary’ glucose-negative E. 
coli strains resulted in up to 50 % improvement in biomass productivity compared to the 
monocultures. The improvements were gained through the consumption of end-
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metabolites by the secondary strain, thus neglecting the growth inhibiting effects of 
byproducts, namely acetate (Bernstein et al. 2011). Using similar strategy, cocultures 
can be engineered for a simultaneous catabolism of different sugars allowing more 
efficient utilization of heterogeneous feedstocks such as lignocellulose hydrolysates 
(Eiteman et al. 2008). Interestingly, cocultures can also promote cell survival and 
resistance to environmental perturbations by coordinated cell self-organization; 
Brenner and Arnold demonstrated the formation of non-random spatial structures by 
symbiotic engineered E. coli strains resulting in improved biomass accumulation and 
population persistence (Brenner and Arnold 2011). 
As a topical subject, sustainable bioenergy production is a target field in which 
coculturing can be exploited to tackle challenges related to product tolerance, efficient 
utilization of industrial heterogeneous substrates, and endured robustness and stability 
in large-scale bioprocesses. For the improved production of bioethanol, cocultures 
employing task distribution in engineered populations have been described; in a study 
by Shin et al. (2010) two E. coli populations were differentially engineered to produce 
and secrete hemicellulases for hemicellulose hydrolysis, and to convert the sugars to 
ethanol in a single-step process (Shin et al. 2010). In another study by Tsai et al. 
(2010), a consortia comprising of three different yeast strains was engineered to 
display a minicellulosome for a direct conversion of cellulose to simple sugars, followed 
by a conversion of glucose to ethanol (Tsai et al. 2010). For improved hydrogen 
production, coculturing Clostridium butyricum and E. coli resulted in increased 
hydrogen titers and more efficient glucose utilization compared to the monocultures 
(Seppälä et al. 2011).  
Regot et al. (2011) introduced a synthetic biology approach to establish a multicellular 
network for distributed biological computing, enabling the construction of a complex 
synthetic device constituting of multiple Boolean logic gates (Regot et al. 2011). In the 
study, yeast cells were engineered to exhibit different functions according to defined 
inputs and an output, which could be combined and connected by multiple ways, 
resulting in the construction of complex synthetic circuits. It was demonstrated that 
using only 2-5 cell types and three inputs in the system, hundreds of different functions 
could be executed. Exploiting consortia instead of a single strain for computing allows 
the construction of more complex, combinatorially powerful, and programmable genetic 
circuits not realizable in a single cell.  
Harnessing quorum sensing mechanisms for coordinated task performance enables 
the construction of spatially and temporally defined networks. The study of Basu et al. 
(2005) beautifully demonstrates the power of engineered multicellular communication 
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systems in the formation of programmed visual patterns and shapes. The pattern 
formation is based on ‘sender’ cells producing acyl-homoserine lactone (AHL), typical 
bacterial signaling molecules, and ‘receiver’ cells, producing fluorescent protein in 
response to defined concentration of AHL. The sophisticated activator-repressor 
regulator system resulted in protein expression only at a certain distance from the 
sender cell (Basu et al. 2005). In a study by Tamsir et al. quorum sensing molecules 
were used as connectors between simple gates in different cells, allowing the 
construction of all 16 type of logic gates according to the spatial arrangement of sender 
and receiver cells (Tamsir et al. 2011).  
For the lack of universal genetic tools and limited knowledge on the metabolism and 
genetics of potential hosts, most of the reported rationally engineered coculture 
systems involve two or more strains or mutants of the same species. Especially in 
synthetic biology, the work is mostly concentrated on E. coli or S. cerevisiae based 
systems, thus partly limiting the coculture characteristics and potential. However, using 
different species in a coculture is supported by certain aspects; potentially more 
orthogonal process design can be achieved due to the lack of specific inter-species 
quorum sensing and regulatory mechanisms. Also, the different carbon metabolism 
patterns allow more efficient utilization of a wider range of carbon molecules and 
restrain the accumulation of a single compound in the culture. In scale-up processes, 
susceptibility to bacteriophage contamination can be decreased by using two species 
instead of a single strain. In future, the increasing number of well-characterized genetic 
tools and alternative synthetic biology hosts will probably expand the field of coculturing 
towards well-defined robust multicellular systems, with distinct properties superior to 
single-cell based pure cultures. 
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5 Hypotheses and objectives of the study 
The sustainable production of bioenergy molecules and other industrially relevant 
compounds is one of the central goals of synthetic biology. Long chain hydrocarbons 
such as fatty aldehydes, fatty alcohols, triacylglycerols and wax esters are exploited by 
several industries for a broad range of applications. The demand for biological 
production systems is growing to replace conventional processes using fossil or food-
chain related feedstock. In order to achieve sufficient production rates, profound 
understanding about the biosynthesis pathways and regulatory systems is required. As 
a major challenge with regard to hydrocarbon production is the limited availability of 
dynamic, high-throughput monitoring and analysis tools; the conventional methods are 
laborious, time-consuming, and they reveal no information about the production 
dynamics. 
Efficient tools and expression systems are required in the construction of a robust cell 
factory. However, an optimal chassis with desired characteristics is of equal 
importance. Certain aspects such as comprehensive knowledge on the cell genetics 
and metabolism, and availability of straight-forward engineering tools are essential, but 
the special features of the cellular machinery should be individually considered 
according to the application; does the cell provide the required precursors or cofactors 
at sufficient rate? Is there a need for extensive ‘construction work’ to enable the 
expression of the pathway? How does the cell cope with the physiological and 
environmental perturbations caused by the built system? How could the natural 
properties of the cell be efficiently exploited? In addition to optimizing the host cell, 
possibilities for multicellular approach promoting task distribution and metabolic 
balancing should be considered. 
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To fully realize the production process, that is, to take the process to an industrial 
scale, issues related to patents and licensing need to be considered. Despite 
Escherichia coli often being the most convenient choice for a process, IPR issues can 
put obstacles in the way. 
To sum up, my study considers the above mentioned limitations, issues, and 
challenges of existing synthetic biology production systems and approaches with 
regard to long chain hydrocarbon production and demonstrates the possibilities and 
benefits of exploiting an alternative bacterial host, Acinetobacter baylyi ADP1, as a 
cellular factory and model system for synthetic biology.    
The specific objectives and hypotheses of the study are: 
1. To establish a model platform based on A. baylyi ADP1 for the 
improved production of lipid compounds employing metabolic 
engineering approach (I) 
 
According to the hypotheses, the previously constructed metabolic model 
can be exploited to find gene deletion targets that beneficially affect the 
lipid, or more specifically, triacylglycerol production. The genome 
engineering can be conducted by established molecular methods and the 
predictions are verified experimentally. Single and/or multiple gene 
deletions increase the lipid titers, productivity or proportion of 
triacylglycerols in total lipids. The results give important clues of the 
significance of gene deletions to the lipid metabolism of A. baylyi ADP1.   
 
2. To develop a dynamic in vivo tool for studying and monitoring the 
long chain hydrocarbon metabolism (II) 
 
According to the hypotheses, the reporter enzyme bacterial luciferase can 
be employed as a sensor for intracellular long chain aldehydes. The 
presence of aldehydes can be detected by measuring bioluminescence 
produced by the bacterial luciferase. As aldehydes are specific and 
dynamic intermediates of the wax ester synthesis pathway in A. baylyi 
ADP1, monitoring the bioluminescence gives important information about 
the wax ester synthesis patterns and production kinetics. The monitoring 
system can be exploited in the optimization of the production host and 
conditions. The tool can be also applied to other pathways involving 
aldehyde intermediate. 
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3. To demonstrate the significance of an optimal chassis; developing a 
monitoring tool for studying alkane metabolism by the integration of a 
well-known DNA component to a novel context  (III) 
 
According to the hypotheses, previously described biosensors for alkane 
detection can be replaced with a simpler design by choosing an optimal cell 
framework exhibiting the relevant pathway(s) combined with an appropriate 
sensor element. A. baylyi ADP1 provides the required biocomponents for 
alkane uptake and processing. Degradation of alkanes produces an 
aldehyde intermediate which can be detected by the bacterial luciferase. 
The constructed system not only enables the detection of alkanes, but also 
provides fundamental information about the natural degradation kinetics 
and patterns.     
 
4. To reconstruct the wax ester synthesis pathway for modified products 
in A. baylyi ADP1 using synthetic biology tools (IV) 
 
According to the hypotheses, the chemical composition of the wax esters of 
A. baylyi ADP1 can be modified by replacing a natural key enzyme of the 
pathway with an alternative enzyme exhibiting a defined substrate range. A 
well-characterized biocomponent, fatty acid reductase complex LuxCDE, 
can be employed for the wax ester synthesis. The reductase complex 
provides aldehyde precursors mostly consisting of C10-14 chains, resulting 
in alcohol moieties of respective chain lengths in the final product. 
Introducing the synthetic pathway allows the regulated production of a 
custom-made bioproduct.  
 
5. To design and engineer a synthetic coculture for improved cell 
performance and product formation (V) 
 
According to the hypotheses, using a glucose-negative mutant strain of A. 
baylyi ADP1 supports E. coli growth in a coculture by efficiently removing 
toxic acetate from the culture medium. This improves the E. coli biomass 
production and reduces the need for process control and optimization. Both 
strains can be harnessed for the production of a relevant compound by 
well-established engineering tools. The product titers in a simple batch 
5 HYPOTHESES AND OBJECTIVES OF THE STUDY 
 
53 
 
process coculture are higher compared to the corresponding pure cultures 
of E. coli.    
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6 Summary of materials and methods 
The details for the materials and methods used in the studies are described in papers I-
V. 
6.1 Strains 
Acinetobacter baylyi ADP1 (available at German Collection of Microorganisms and Cell 
Cultures, under accession number DSM 24193) was used in the studies as the wild 
type strain. Single gene knockout mutant strains (Table 5.1) were kindly provided by 
Veronique de Berardinis (Genoscope, France). In the single gene knock-out mutants, 
the gene in question is replaced with a gene cassette containing a kanamycin 
resistance gene (kanr). Double and multiple gene knockout strain constructions are 
described in ‘genetic engineering’ section. For coculture studies (V), E. coli K12 
BW25113 (from Yale E. coli Genetic Stock Center CGSC, Connecticut, USA) was 
used.  
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TABLE 6.1. Single gene knockout mutant strains used in the studies. 
 
6.2 Genetic engineering 
The molecular work was carried out by standard procedures (Sambrook et al. 1990) or 
according to BioBrick cloning standard (Shetty et al. 2008). Primers were ordered from 
ThermoFisher Scientific (USA) with appropriate restriction sites. 
6.2.1 Plasmid and gene cassette construction 
An integrative gene cassette was used as a scaffold for genomic deletions and 
insertions (I, II, III, IV). The gene cassette (Figure 6.1) was constructed in vitro and 
contains the following components: 1) a flanking region upstream of the target gene, 2) 
a promoter, 3) a multiple cloning site (MCS), 4) a selection marker, 5) a transcription 
termination loop, and 6) a flanking region downstream of the target gene. 
gene ID Gene name Gene product EC Reference
ACIAD2837 dgkA diacylglycerol kinase EC 2.7.1.107 I
ACIAD3383 acr1 fatty acyl-CoA reductase EC 1.2.1.n2 I, II, III, IV
ACIAD2844 glpD
glycerol-3-phosphate 
dehydrogenase
EC 1.1.5.3 I
ACIAD2425 cyoA
cytochrome o ubiquinol 
oxidase subunit II
EC 1.10.3.- I
ACIAD2426 cyoB
cytochrome o ubiquinol 
oxidase subunit I
EC 1.10.3.- I
ACIAD2291 cydB
cytochrome d terminal 
oxidase polypeptide subunit 
II
EC 1.10.3.- I
ACIAD3381 poxB
pyruvate dehydrogenase 
(cytochrome)
EC 1.2.2.2 I
ACIAD3648 estA carboxylesterase EC 3.1.1.1 I
ACIAD1134 aesT esterase - I
ACIAD3309 - l ipase EC 3.1.1.3 I
ACIAD1121 lip1 triacylglycerol l ipase EC 3.1.1.3 I
ACIAD0544 gntT
high-affinity gluconate 
permease (GntP family)
- V
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FIGURE 6.1.The synthetic gene cassette employed for targeted gene deletions and 
chromosomal insertions. 5’ flank – a homologous region upstream the target 
site, T5/lac – a promoter, RBS – Ribosome binding site, MCS – multiple 
cloning site, cm(r) – chloramphenicol resistance gene cat, Ter – transcription 
termination loop, 3’ flank – a homologous region downstream of the target 
site.  
For plasmid expression in ADP1 (IV, V), vectors derived from pBAV1K (Murin et al. 
2012) were used (Figure 6.2).  
 
FIGURE 6.2.The expression vector pBAV1C-T5-gfp. The reporter eGFP is expressed 
under a T5/lac promoter. The vector contains the restriction sites for BioBrick 
cloning. The described construct was used in In paper V, whereas in paper IV 
pBAD and luxCDE replaced the T5/lac and gfp. 
All the genetic constructs used in the studies are listed in Table 6.2. 
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TABLE 6.2. The list of genetic constructs used in the studies. 
 
6.2.2 Transformation 
Transformations of E. coli were carried out by standard electroporation procedures 
(Sambrook et al. 1990). For natural transformation of ADP1, a methodology described 
previously was used (Metzgar et al. 2004); a linear DNA fragment (PCR product) with 
flanking regions of the target site in genome or plasmid vector was inserted to ADP1 
cultivation in an exponential growth phase. The cultivations were conducted at 30 °C 
and stirring of 300 rpm using LB medium or MA/9 minimal salts medium supplied with 
glucose. For transformation, 1-2 µg DNA was used per 1 ml of cultivation. After 
insertion, the cultivations were incubated for 2-3 h and then spread on a selective LA 
plate supplemented with glucose and appropriate antibiotic. Concentrations for 
selective antibiotics were 30-50 µg/ml for kanamycin, 25-50 µg/ml for chloramphenicol, 
and 10 µg/ml for tetracycline, respectively. The plates were incubated at 30 °C until 
colonies appeared. Negative controls were cultivated in the same method except for 
insertions sterile water was used instead of DNA. The constructs in the obtained strains 
were verified with colony PCR and further by sequencing. 
6.3 Cultivations 
A modified Luria-Bertani medium (V; 1 g/l NaCl, 5 g/l yeast extract, 10 g/l tryptone, 2 
mM MgSO4, 0.5 mM CaCl2, 3 µM FeCl3) or minimal salts medium MA/9 (I-V; Na2HPO4 ∙ 
2 H2O 5.518 g/l, KH2PO4 3.402 g/l, NH4Cl 1 g/l, nitrilotriacetic acid 0.008 g/l, NaCl 1.0 
g/l, 2 mM MgSO4, 0.5 mM CaCl2, 3 µM FeCl3, and trace element solution (I)) 
supplemented with a carbon source, casein amino acids, antibiotics, and an inducer, 
when appropriate, was used in the studies. Gluconate (I), glucose (II, III, IV, V), alkanes 
(III) or acetate (V) were used as carbon sources. For bioreactor cultivations (V), a 1-
litre vessel (Sartorius Biostat B plus Twin System, Germany) with online pH monitoring 
Name Type locus Promoter Insert Selection marker Reference
iSM100cz' Integ. cassette ACIAD3381-3383 T5/lac cm I
iluxAB_Cmr Integ. cassette ACIAD3381 T5/lac luxAB cm II, III, IV
pVKK81-T-lux plasmid lac luxCDABE tet V
pBAV1C-ara -luxCDE plasmid BAD luxCDE cm IV
pBAV1C-ara plasmid BAD cm V
pBAV1C-T5-GFP plasmid T5/lac gfp cm V
sfGFP/pAK400c plasmid lac gfp* cm V
*superfolder variant
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system, stirring, and oxygen supply was used. Cultivations were carried out at 20-
37 °C. 
6.4 Output analyses 
The analysis methods and instrumentation used in the studies are presented in Table 
6.3.  
TABLE 6.3. Analytical methods and instruments used in the studies. 
Analysis Method/Instrument Reference 
Biomass 
      Optical density Spectrophotometer, 600 nm I-V 
    Cell dry weight Freeze-drying; gravimetric I-V 
Metabolic predictions In silico simulations; FBA I, V 
Lipids 
       Total lipids Solvent extraction; gravimetric I, II, IV 
 
+ GC-FID I 
 
+ GC-MS IV 
 
+ TLC I, II, IV 
     TAG Solvent extraction I, IV 
 
+ SPE / FAME derivation, GC-FID I 
 
+ preparative TLC; gravimetric I 
 
+ HPLC-GPC IV 
     WE Solvent extraction I, II, IV 
 
+ TLC I, II, IV 
 
+ NMR 
      FA, Alcohols Solvent extraction, GC-FID, GC-MS IV 
Sugars, end-metabolites HPLC I, II, V 
Luminescence Microplate Reader (Victor 2) II, III, IV, V 
 
Xenogen IVIS Lumina II II, III 
Fluorescence Microplate Reader  
   (Fluoroskan Ascent FL, ex/em 485/538) V 
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7 Summary of results and discussion 
This chapter provides an overview of the results obtained in the research, and compiles 
the thoughts and future prospects arisen during the process. The individual results and 
observations are more specifically discussed in the original papers I-V. 
7.1 Improving the lipid quantity and quality (I, IV)  
For the improved production of TAGs in A. baylyi ADP1 (I), computational tools and 
manual comparative analysis were exploited in identifying target genes for the 
elimination of potential competitive pathways and the redirection of product precursors. 
An extended constraint-based metabolic model of ADP1 was employed for the 
computational analysis. After a preliminary screening of eleven potential individual 
single gene knock-out mutants (Figure 7.1), the four most relevant deletions, fatty acyl-
CoA reductase acr1 (ACIAD3383), pyruvate dehydrogenase poxB (ACIAD3381), 
diacylglycerol kinase dgkA (ACIAD2837), and a triacylglycerol lipase (ACIAD3309), 
were chosen for further studies. Briefly, the hypotheses of the effects of these deletions 
on TAG metabolisms were the following: A strain lacking a fatty-acyl-CoA reductase is 
incapable of wax ester synthesis, thus redirecting the carbon flow towards TAG 
synthesis. Eliminating the TAG lipase potentially prevents the degradation of the 
product of interest. The diacylglycerol kinase directs 1,2-diaclyglycerol, an important 
precursor of TAG, to phospholipid synthesis competing with TAG synthesis. The 
pyruvate dehydrogenase is associated to acetate production, and therefore the deletion 
can redirect the carbon flux towards storage lipid synthesis. 
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FIGURE 7.1.The metabolic pathways of ADP1 relevant to the storage lipid metabolism. The 
ACIAD gene numbers of the potentially beneficial gene deletions are shown. 
The specific functions of the genes and the effect of deletions on the TAG 
synthesis are described in paper I and in (Aho et al. 2012).  
Three of the deletions (i.e. acr1, poxB, and the triacylglycerol lipase) were combined in 
a single strain (referred as strain MT). As a result, the strain MT produced 5.6 fold more 
triacylglycerol (mg/g cell dry weight) compared to the wild type strain, and the 
proportion of triacylglycerols in total lipids was increased by 8-fold. Of individual 
deletions, the acr1 knock-out eliminating the WE pathway had the most impact on TAG 
synthesis; this was further confirmed by the subsequent analyses (IV) showing that the 
diacylglycerol precursors are strongly directed to TAG synthesis in the acr1 mutant. In 
addition, it has been suggested that when alcohol substrate is available in a cell, the 
activity of WS/DGAT is strongly shifted towards WE synthesis (Kalscheuer and 
Steinbüchel 2003; Kaiser et al. 2013), thus relatively increasing the TAG synthesis in 
the absence of fatty alcohols. By contrast, deleting the poxB or the hypothetical lipase 
ACIAD3309 results in an increased WE production (Aho et al. 2012).  
The study experimentally validated the computationally simulated effects of gene 
knock-outs on the lipid metabolism of ADP1 and proved the coupled effect of 
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combining several gene deletions. The study demonstrates the convenience of the 
strain ADP1 as a host for metabolic engineering purposes and the potential for further 
investigation as a lipid production platform.   
The obtained results give indications of the mechanisms affecting the natural lipid 
synthesis. While metabolic models can indeed predict the effect of gene deletions on 
the cell metabolism, the coverage of predictions is restricted to the predetermined 
reactions. Therefore, all potential bottlenecks and carbon consuming routes which 
indirectly affect the lipid production are not identified by the model. For example, the 
extracellular polysaccharide (EPS) production known to consume significant amounts 
of carbon (Kaplan and Rosenberg 1982) were not considered in the simulations. 
Furthermore, in the steady-state assuming constraint-based model the gene 
expression levels or the growth phase are not taken into account, resulting in a 
qualitative rather than a quantitative output. In addition, the homology-based annotation 
of genes can lead to inaccurate or false predictions.  
For a metabolic model to be truly useful, a continuous evolvement and validation are 
required. For example, the latest update of the genome-wide metabolic model of E. 
coli, EcoCyc–18.0–GEM, encompasses 1445 genes, 2286 reactions, and 1453 
metabolites, afforded by a comprehensive integration of computational and 
experimental data directly from EcoCyc database (Weaver et al. 2014). According to 
the developers, the new model offers easy operation, frequent updates, and more 
accurate predictions enabling the more advantageous use of the computational 
simulations. For ADP1, the on-going experimental annotation of genes and profound 
analyses of the transcriptomic and metabolic data can provide means to develop a 
more accurate and quantitative model for ADP1 (Genoscope 2009; Stuani et al. 2014). 
Owing to the laborious and multi-step nature of the preparative TLC analytics 
conducted, the TAG production of only a very limited number of knock-out strains was 
thoroughly studied. Furthermore, the screening of several knock-out combinations in a 
single strain could have resulted in further improved productivity. For example, the 
deletion of diacylglycerol kinase dgkA was considered an interesting knock-out target, 
but the low biomass yields prevented an accurate determination of the TAG yield of the 
strain. Recently, it was shown that the deletion of dgkA combined with the 
overexpression of WS/DGAT from ADP1 and fadD from E. coli resulted in a 
considerably improved production of TAG in E. coli (Janßen and Steinbüchel 2014). 
Similarly to our study, the negative effects of dgkA deletion on growth were observed. 
Nevertheless, in an optimized fed-batch bioprocess, TAG titers of 530 mg/l (8.5 % of 
CDW) could be achieved (Janßen and Steinbüchel 2014).  
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The study of Janßen and Steinbüchel demonstrates the necessity of both gene knock-
outs and gene overexpression in achieving significant improvements at the cell level. 
Moreover, a comprehensive bioprocess optimization is required to obtain improved 
volumetric yields, since the synthesis of neutral lipids strongly competes with biomass 
production. Although the main goal of my research was to investigate the effects of 
gene deletions on the lipid metabolism rather than to maximize the productivity, the 
overexpression of selected key enzymes could have provided important clues of the 
rate-limiting steps. For example, in the present E. coli based production systems the 
overexpression of fadD and ‘tesA, combined with the deletion of fadE, are almost 
routinely done to improve the supply of FA precursors (see Chapter 3.1.3). 
Interestingly, the overexpression of the ADP1 thioesterase, which is the corresponding 
enzyme for the widely applied TesA, has been shown to significantly improve the FA 
synthesis in E. coli (Zheng et al. 2012a). Therefore, in our on-going studies the early 
steps of the lipid production pathway are investigated, involving both the heterologous 
expression of non-native genes and regulation of the natural pathway (data not shown). 
In natural hosts, the synthesis of storage lipid is regulated by environmental conditions, 
a nutrition supply, and the growth phase. For example, nitrogen limitation in a 
stationary growth phase is known to induce lipid accumulation in bacteria (Ishige et al. 
2002; Wältermann et al. 2005). Bypassing the natural regulation can thus significantly 
increase the production rates. However, very little is known about the molecular 
mechanisms affecting the lipid accumulation. For R. opacus, a gene contributing to the 
regulation of lipid metabolism was previously identified (MacEachran and Sinskey 
2013). In nitrogen limiting conditions, the gene (referred as tadD) was shown to 
metabolize glyceraldehyde-3-phosphate to 3-phosphoglycerate yielding NAD(P)H, a 
crucial cofactor for fatty acid biosynthesis. For ADP1, however, protein homologous to 
the described TadD is not present. 
The first attempt to regulate the lipid synthesis of ADP1 was made in reconstructing the 
WE synthesis pathway (IV). The natural fatty-acyl CoA reductase Acr1 was replaced 
with a well-characterized FA reductase (FAR) complex LuxCDE from P. luminescens. 
The rewired pathway employing an inducible arabinose promoter pBAD enabled a 
regulated production of synthetic WEs. The study also revealed a strong temperature 
dependency of the WE production: within a range of 20-37 °C, most WEs were 
produced at 20 °C. Due to the different substrate specificity of LuxCDE compared to 
Acr1, the WE profile of the engineered strain was altered; the alkanol chains of the 
synthetic WEs were slightly shorter and more saturated in comparison with the WEs of 
the wild type strain, the major constituent being C16:0 alkanols. Furthermore, C12:0 
alkanols, which are very rare in the wild type strain, were detected in the engineered 
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strain. However, the most preferred substrates of LuxCDE, C14 alkyl groups, were 
absent. As discussed in paper IV, most probably the native aldehyde reductases affect 
the final product quality. Thus, a feasible approach for neglecting the endogenous 
aldehyde reductase(s) could be an expression of a multifunctional FAR that converts 
the FA (-CoA or -ACP) substrates directly to alcohols without the aldehyde 
intermediate.  
Even though the product titers were not improved by the synthetic pathway, the results 
encourage for further development and enhancement of the WE synthesis platform. 
Furthermore, demonstrating the utility of the well-characterized LuxCDE complex in the 
production of hydrocarbons extends the possibilities to choose the most optimal 
components to build up pathways with specified properties and modularity. Evidently, 
the increased knowledge on the enzyme functions and pathways facilitates the 
expansion of the synthetic biology product repertoire (Layton and Trinh 2014; 
Rodriguez et al. 2014). 
With regard to the obtained titers of synthetic WEs, there are several potential reasons 
why the reconstructed system did not increase the WE production rates. Firstly, 
considering the role of LuxCDE in its natural context, the activity of the enzyme 
complex is probably not very high; consuming large amounts of cofactors and valuable 
carbon molecules for bioluminescence production would not be energetically 
affordable. In addition, in the constructed expression platform natural regulatory 
elements upstream of LuxE were disrupted, thus potentially affecting the expression 
levels. Furthermore, the bacterial luciferase and the FAR complex assumingly recycle 
the FA substrate in the reactions, thus not significantly interfering with the natural lipid 
metabolism of the cell. This indicates a relatively low catalytic activity and affinity of 
LuxD towards the activated cellular FAs, which in turn implies minor contribution of 
LuxD to the WE synthesis, as discussed in paper IV. Furthermore, as implied by 
Smanski et al. (2014), a simple insertion of a component without further optimization 
very improbably increases the production rates.   
By contrast, the introduction of an alternative LuxCDE complex from Vibrio harveyi 
resulted in production of tetradecanol (C14) in E. coli (Rodriguez et al. 2014). A 
simultaneous expression of an ester forming acyltransferase Atf1 from S. cerevisiae led 
to the production of tetradecyl acetate. It is unclear why the described expression 
platform produced C14 acyl groups, while they were not detected in the WEs of the 
engineered ADP1 (IV). This discrepancy can be due to the very different cellular 
environments of the hosts. For example, the ADP1 enzymes involved in the lipid 
synthesis are typically membrane-bound and may possess unique enzymatic 
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interactions affecting the substrate flow and preference (Wältermann et al. 2005). In 
addition, the differences in the specificities between the endogenous alcohol 
dehydrogenases of E. coli and ADP1 probably affect the product quality. It is also 
possible that the V. harveyi and P. luminescens FAR complexes, and more specifically 
the LuxD counterpart, exhibit differential activity (the acyltransferases show 70 % 
similarity at the amino acid level). For example, the higher affinity of the V. harveyi 
LuxD towards tetradecanoyl-ACPs would theoretically terminate the FA elongation and 
allow the assimilation of C14 FA for aldehyde synthesis.  
The insufficiency of the P. luminescens LuxD to provide C14 acyl groups for aldehyde 
synthesis in a recombinant host was also observed by Howard et al (2013). The P. 
luminescens LuxCDE FAR complex and an aldehyde decarbonylase (NpAD) were 
exploited in the production of variable branched and aliphatic alkanes. The study 
utilized the FAR complex for a direct conversion of free FAs to aldehydes. This 
approach was suggested to allow a more tractable specification of the output products 
via the modifications of the cellular FA pool. It is noteworthy that the acyltransferase 
LuxD is previously described to utilizing activated FAs as a primary substrate (Meighen 
1991). To elucidate this contradiction, the study showed that free FAs can be directly 
converted to aldehydes by LuxE and LuxC solely. The potential of LuxC to directly 
accept activated FAs for the reduction reaction has been also discussed in the 
literature (Wall et al. 1986). In the study of Howard et al., providing exogenous FAs or 
introducing a specific thioesterase activity, such as FatB1 from Cinnamomum 
camphora, resulted in the production of alkanes with acyl groups of corresponding 
lengths. However, in the presence of LuxCDE and NpAD solely, only minor proportions 
of the predicted C13 alkanes (yielding from C14 aldehydes) were produced, thus 
demonstrating the redundancy of LuxD in terms of the transferase activity. However, it 
was proven that the role of LuxD, albeit not completely clarified, is significant for the 
catalytic activity of LuxC and LuxE through protein-protein interactions, thus supporting 
the findings of my study (paper IV, suppl.). Altogether, elucidating the role of LuxD, and 
especially the possibility to engineer the FA(-CoA) pool of ADP1 require further 
research efforts. Moreover, our future studies will involve the screening of other 
potential reductases and thioesterases in terms of improved WE production. 
Similarly to TAG production, not much is known about the regulation or expression 
levels of the key enzymes of the WE synthesis pathway. For example, the molecular 
mechanisms behind the temperature dependency of WE production are not 
established. It has been shown, however, that only a few copies of the terminal 
enzyme, WS/DGAT, are present in the cells (Wältermann et al. 2005). We have 
conducted preliminary studies to investigate whether an overexpression of the native 
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enzymes improves the WE production. The early results indicate that the 
overexpression of acr1 increases the amount of WEs in ADP1, whereas increased 
WS/DGAT levels do not significantly affect the WE production in the studied conditions 
(data not shown). Although numerous studies have exploited the ADP1 originated 
WS/DGAT in the production of esters, other potential acyltransferases/wax ester 
synthases have been introduced (Barney et al. 2012; Shi et al. 2012). Thus, in order to 
overcome the potential limitations with regard to the native regulation and product 
range, the expression of a non-native terminal acyltransferase for lipid production in 
ADP1 might be profitable. 
While only modest WE titers were achieved using glucose as a substrate (II, IV), it is 
known that ADP1 naturally produces large amounts of WEs when grown on alkanes. 
Ishige et al. (2002) obtained 17 % WEs of the cell dry weight in a 10 h cultivation using 
3 % n-hexadecane as a substrate. The WEs were almost exclusively (98 %) found to 
compose of hexadecyl-hexadecanoate, indicating the possibility for very precise 
determination of the product quality. Even though refined alkanes are not currently 
considered as a sustainable carbon source, elucidating the mechanisms behind the 
efficient conversion of long chain hydrocarbons to WEs could promote the processes 
exploiting more appropriate carbon sources. On the other hand, streams containing 
impure alkanes, such as waste streams or oil spills, could serve as an economical and 
sustainable substrate for an efficient recovery of the hydrocarbons in the form of 
valuable WEs. 
Altogether, ADP1 can be concluded to possess potential for the production of long 
chain hydrocarbons, especially WEs. What is more, a lot of engineering and research 
efforts have been dedicated to redirect and increase the central carbon flux of E. coli 
towards acyl-CoAs, the key precursors of valuable hydrocarbons (Xu et al. 2014). As a 
natural producer of acyl-CoA derived hydrocarbons, the central carbon metabolism of 
ADP1 is able to provide acyl-CoAs at sufficient rates. Furthermore, the existing 
metabolic network for the long chain hydrocarbon production endorses the 
straightforward construction of several relevant pathways in ADP1. However, in 
addition to engineering the individual enzymatic steps to increase the supply of 
precursors, the redox balance (Singh et al. 2011) and cofactor regeneration (Wang et 
al. 2013; Akhtar and Jones 2014) need to be considered. As an alternative to produce 
biomolecules through fermentations from simple sugars, the catalytic diversity of ADP1 
could afford selective biotransformations to produce enantiomerically pure 
biomolecules from provided precursors (Ishige et al. 2005; Molinari 2006). 
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7.2 Constructing tools for monitoring the hydrocarbon 
metabolism of ADP1 (II, III) 
Conventionally, the lux multienzyme complex has been utilized in an orthogonal 
manner, i.e. independent of the host metabolism. The complex can be divided into two 
functional parts, an aldehyde producing unit LuxCDE, as demonstrated in paper IV, 
and a fatty acid and light producing unit LuxAB. In my study, the functional units of the 
lux complex were exploited independently and integrated into the ADP1 metabolism. 
The aldehyde producing unit provides intermediates for the production of customized 
long chain hydrocarbons, and vice versa, the integration of the light producing unit 
enables the detection of endogenous long chain aldehyde formation. 
The bacterial luciferase LuxAB from P. luminescens was exploited in constructing a 
real-time monitoring tool for studying the WE production of ADP1 (II). The P. 
luminescens luciferase was chosen for its high stability (Szittner and Meighen 1990). 
The sensor represents a post-translational (metabolite level) detection of the target 
molecule; the detection of WE formation is based on the light-producing reaction 
between the bacterial luciferase enzyme and a fatty aldehyde molecule (Figure 7.2). 
The long-chain aldehyde molecule represents a specific intermediate of the WE 
synthesis route, enabling a very sensitive and specific detection of the molecule. 
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FIGURE 7.2.The proposed WE synthesis pathway of ADP1. The integration of the bacterial 
luciferase (LuxAB) enables the real-time detection of the fatty aldehyde 
intermediate. The fatty acid molecule produced in the reaction is returned to 
the carbon cycle (Modified from paper II). 
Monitoring the WE production in variable conditions showed correlation between the 
luminescence signal and the WE synthesis pattern, which was further verified with TLC 
and NMR analyses. The experiments revealed that WEs are dynamic storage 
molecules, which are produced and degraded in the cells in different phases of the 
cultivation. Furthermore, it was confirmed that the WE synthesis is activated in nitrogen 
limiting conditions. Expressing LuxAB in ADP1 did not significantly affect the WE 
production rates compared to the wild type strain, indicating that only minor metabolic 
burden is caused by the tool expression. 
The described monitoring system serves as a valuable tool for complementing the 
laborious lipid analysis methods, especially in high-throughput studies and screening 
purposes. The sensor does not require inclusion of an external substrate, and thus the 
monitoring of cultivations can be conducted in an automated manner without sampling. 
Moreover, the tool provides new information regarding the WE production dynamics, 
not interpretable by conventional means. In our recent studies, the monitoring tool has 
been exploited in screening optimal carbon sources and growth temperatures for WE 
production (data not shown).  
7 SUMMARY OF RESULTS AND DISCUSSION 
 
68 
 
The well-characterized and widely applied bacterial luciferase can be readily expressed 
in a variety of hosts. Apart from studying the native WE metabolism of ADP1, the tool 
has shown promise in searching novel reductase and dehydrogenase activities, 
demonstrating its applicability in a broad range of hosts and applications (data not 
shown). Furthermore, as the long chain aldehyde serves as the key intermediate of the 
pathways leading to fatty alcohol, fatty alkyl ester, and alkane synthesis, the tool could 
be potentially generalized for the optimization of advanced biofuel and other valuable 
hydrocarbon production.  
Given that the luminescence emission is a result of direct reaction between the 
substrate and the enzyme present in the cells, the described tool provides an instant 
and dynamic response to changing aldehyde levels in the cell. Thus, in contrast to the 
biosensors functioning through transcription regulation, the described system naturally 
exhibits very high dynamical range. Furthermore, it is not dependent on the 
transcription and translation machineries during the detection event, and the lag time 
between the aldehyde formation and luminescence emission is only dependent on the 
diffusion of the molecules (<0.1 s). Even though not investigated in paper II, the 
sensitivity and the rate of the tool can be potentially even further tuned by adjusting the 
luciferase expression levels. 
Despite solving some major limitations of lipid analytics, few issues that are not 
discussed in paper II exist. For example, the amplitude of the luminescence signal is 
dependent on the substrate, i.e. aldehyde chain length and properties, and thus the 
signal cannot be considered quantitative. Therefore, the signal patterns rather than 
absolute signals are of higher significance. Moreover, the different affinities towards the 
aldehyde substrates limit the comparability of results obtained from different culture 
types, hosts, and target products. As bacterial luciferases are generally applied for 
acting on aliphatic aldehydes with a typical range of C8-C14 acyl groups, it would be 
interesting to study the enzyme potential of utilizing other types of aldehydes, such as 
branched, unsaturated, or cyclic aldehydes as substrates. Thus, in order to take a full 
advantage of the tool harnessed for metabolic studies, insightful knowledge on the 
substrate range and engineering potential of bacterial luciferases in the light of 
synthetic biology is required. 
Furthermore, it should be taking into account that different bacterial luciferases (e.g. 
Vibrio vs. Photorhabdus) may possess different substrate preference and catalytic 
activity depending on the conditions. On one hand, the distinct properties of the 
luciferases, such as the heat lability of Vibrio spp. luciferases (Escher et al. 1991), can 
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be potentially exploited in selective and dynamic redirecting of metabolic fluxes, 
evolving the idea of Falls et al (2014) introduced in Chapter 3.2.1. 
Aldehydes themselves are important molecules. In addition to being key intermediates, 
i.e. one catalytic step away from alcohols, alkanes, FAs, and WEs (Kaiser et al. 2013), 
aldehydes have intrinsically industrial use, for example in the food industry, and in the 
synthesis of plastics and  rubbers. Moreover, compared to alcohols, the high volatility 
of aldehydes simplifies the product recovery and alleviates the product toxicity to cells. 
As a natural producer, the strain ADP1 serves as a potential host for the production of 
aldehydes. However, the endogenous aldehyde reductases which further convert the 
aldehydes to alcohols complicate the sufficient production of aldehydes as the final 
product. Rodriguez and Atsumi have comprehensively investigated the E. coli 
reductases to allow an efficient production of aldehydes and alkanes; the deletion of 
five potential reductases coupled with a relevant pathway engineering of E. coli 
resulted in production of 35 g/l isobutyraldehyde and 10 g/l isobutanol (Rodriguez and 
Atsumi 2012). The work was previously continued with the elimination of all 13 known 
aldehyde reductases, resulting in 90-99 % loss of aldehyde reducing activity 
(Rodriguez and Atsumi 2014). It can be speculated, that ADP1 probably contains 
several reductases exhibiting such activity. The key aldehyde reductase(s) involved in 
the WE synthesis pathways has yet to be characterized although some suggestions 
have been presented (Kaiser et al. 2013).   
It was proven that the degradation of WEs in carbon limiting conditions did not 
generate background luminescence emission and thus not interfered the specific 
monitoring of WE synthesis. It was shown, however, that the sensor system could be 
modified for the monitoring of alkane degradation (paper III). Deleting the fatty acyl-
CoA reductase acr1 eliminates the aldehyde production from endogenous sources, 
thus allowing the unambiguous detection of alkane degradation by the bacterial 
luciferase (Figure 7.3). 
The monitoring system was demonstrated to be applicable to the studied range of 
aliphatic alkanes C12-18 and for diesel fuel. The tool was functional both for cells 
actively growing on alkanes and for static cell cultures exposed to alkane samples. 
Furthermore, the tool possessed high stability in longer cultivations. Thus, the sensor 
can be proposed for investigating the kinetics of alkane degradation as well as for the 
detection of alkanes or fuel components in environmental samples. Furthermore, the 
tool holds potential for the screening of alkane degrading or alkane producing strains or 
new enzymatic activities. 
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FIGURE 7.3.The proposed alkane degradation pathway of ADP1. The integration of the 
bacterial luciferase (LuxAB) enables the real-time detection of the fatty 
aldehyde intermediate in the catabolic pathway. Elimination of the strain’s 
natural aldehyde producing pathway results in an unambiguous and simple 
monitoring system (modified from paper III). 
The study demonstrates the differences in kinetic responses and signal amplitudes with 
regard to various alkyl chain lengths. While the longer alkanes C16 and C18 turned out 
to be more convenient substrates for biomass production, the shorter C12 alkanes 
resulted in relatively higher luminescence signals. The variables affecting the signal 
development include the transportation efficiencies of different alkanes, and the 
substrate preference of both the bacterial luciferase and the enzymes catalyzing alkane 
oxidization. Furthermore, the tool also detects the extracellular long chain alcohols and 
aldehydes, which could reduce the tool specificity. Therefore, as for the WE monitoring, 
the tools should be further developed by specifying and validating the system for 
different substrates. 
In general, biological robustness can be improved by designing modular and 
hierarchical systems exhibiting dynamic control (Zhu et al. 2012). In addition, 
constructing an optimal genetic platform imposing minor stress to the cells promotes 
the persistence and performance of the host cell. However, it is very difficult to evaluate 
or predict the effects of heterologous gene expression on cells in response to 
environmental perturbations and changing metabolite levels, and introducing multiple 
non-native activities increase the metabolic and physiological burden. Thus, the 
ideology to choose an optimal host cell intrinsically promoting the application has been 
increasingly brought up in the context of synthetic biology (Nandagopal and Elowitz 
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2011; Fisher et al. 2014; Nikel et al. 2014). The described alkane monitoring tool 
represents an example of a systematic and rational approach to a step-wise 
construction of a stripped-down device exploiting an optimal host cell. The sequential 
steps include: 
1) the specification of the target pathway or the product,  
2) the choice and validation of an optimal cell framework to afford the system with 
minor modifications and convenient characteristics with regard to the device 
purpose,  
3) the determination of a specific intermediate or other key compound which is 
a) linked to the synthesis pathway, 
b) compatible with an amenable biosensing component 
4) the design, construction, and validation of the device with appropriate molecular 
components.  
The described monitoring tools demonstrate the straight-forward applicability of ADP1 
framework for integrating standard DNA components to create streamlined and 
operative devices with only few genetic modifications. Theoretically, the metabolic 
characteristics of ADP1 enable the utilization of the network for establishing several 
pathways for the studying and production of relevant biomolecules.  
7.3 Engineering a synthetic coculture (V) 
A rationally designed and engineered coculture of E. coli and A. baylyi ADP1 was 
constructed to improve the cell performance and product formation (V). The coculture 
was engineered to possess a carbon channeling system, which enables an efficient 
removal of a common inhibitory molecule, acetate, from the cultivation, and redirects 
the carbon flow to the biomass and the product. It was shown that using a glucose-
negative mutant strain of A. baylyi ADP1 supported the E. coli growth and recombinant 
protein (GFP) production in variable conditions; as a result of the cocultivation, the E. 
coli biomass and protein production were improved both in minimal and rich medium 
batch cultures without pH control or optimization. Furthermore, it was demonstrated 
that both the strains could be readily engineered to produce GFP with a single genetic 
construct, resulting in improved volumetric titers.  
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As discussed in paper V, the coculture most probably cannot exceed the maximal 
productivity of an optimized fed-batch monoculture. However, the results suggest faster 
growth for the coculture compared to the E. coli monoculture in all studied conditions. 
In batch processes, the cultivation time directly affects the process feasibility and is 
thus an important parameter to consider. The compromise between the maximal 
productivity and process timespan of the two culture types is illustrated in Figure 7.4. 
Furthermore, considering a process development for a new product starting from 
scratch, carefully designed cocultures with less need for optimization provide a shortcut 
to reach the critical level of productivity.   
 
FIGURE 7.4. A hypothetical illustration of a coculture and a monoculture batch processes. 
Productivity P is given as a function of time t. A threshold for an economically  
feasible process in terms of cultivation time and product yield is indicated in 
light grey. An optimized monoculture results in higher maximal productivity 
whereas coculture possesses faster growth.  
Evidently, several factors affect the choice between a monoculture and a coculture. 
Another benefit of the coculture can be realized in processes exploiting sustainable, but 
challenging feedstocks possessing varying sugar concentrations and limited possibility 
for process control and optimization. In such conditions, E. coli can readily shift to 
overflow metabolism, and the environmental perturbations cannot necessarily be 
balanced by a single strain population. Even though strategies for alleviating the 
negative effects of acetate in monocultures are proposed (Wang et al. 2014a), they are 
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often unable to address the other potential issues related to for example substrate and 
metabolite imbalance and carbon loss.  
Substrate costs constitute the major expense in bioprocesses, and therefore industrial 
secondary flows and lignocellulose hydrolysates are preferred substrates. However, 
the toxic compounds present in the liquors restrict their use (Palmqvist and Hahn-
Hägerdal 2000). Acinetobacter spp. are known to tolerate and/or degrade a variety of 
toxic compounds such as phenols, furfurals, and organic acids, including the 5-
hydroxymethylfurfural and ferulic acid present in lignocellulose hydrolysates (Beshay et 
al. 2002; Lopez et al. 2004). Furthermore, our preliminary studies indicate that some 
typical toxic compounds are not only metabolized into a harmless form, but can be 
directed to the synthesis of valuable compounds (data not shown). Thus, exploiting a 
well-designed coculture may broaden the possibilities to exploit challenging 
heterogeneous liquors as substrates. 
For the convenience of the product determination, the functionality of the coculture was 
demonstrated with GFP production. However, the coculture could be potentially 
harnessed for the production of industrially more relevant compounds, such as long 
chain hydrocarbons. Especially for products involving several enzymatic steps and 
intermediates, a task distribution could be a feasible option. Given that E. coli and 
ADP1 exhibit very different metabolic environments, employing the hosts for different 
tasks would allow the optimal use of the benefits and constraints of each host. For 
example, E. coli has been successfully engineered for the overproduction of free fatty 
acids, whereas engineered ADP1 could efficiently convert them e.g. to alkanes or wax 
esters (Lennen et al. 2010). Distribution of functions can solve issues related to 
metabolic burden, carbon flow, metabolite accumulation, and product tolerance. The 
possibilities of cocultures are beyond imagination; the “supercell” environment provides 
unique possibilities to build up dynamic sensory-regulatory interactions, precisely timed 
functions, and complex genetic circuits (Bacchus and Fussenegger 2013).      
Maintaining the robustness of expression systems in industrially relevant conditions is a 
major challenge. Upscaling often leads to the instability of genetic constructs and loss 
of functionality (Moser et al. 2012). In single strain processes, redundant synthesis 
pathways could provide stability, but they impose an unwanted burden to cells (Zhu et 
al. 2012). In contrast, the cocultures involving one common product target naturally 
possess “a genetic backup” facilitating the production stability and endurance. In paper 
V, E. coli and ADP1 were engineered for GFP production with the same genetic 
construct. However, depending on the product, using genetically different expression 
systems or biochemically alternative pathways for the production could improve the 
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process reliability and robustness. For example, employing alternative enzymes that 
consume different cofactors for a specific catalytic step could stabilize the redox 
balance and improve the energy distribution of a culture. Furthermore, the naturally 
different growth phases and metabolisms equalize the physicochemical characteristics 
and fluctuations of the culture.  
A major challenge in building up an ADP1 based process, albeit a coculture, is the lack 
of experience and knowledge on ADP1 bioprocessing. The unique sugar metabolism of 
ADP1 can set constraints for high-cell density cultivations, although efforts to improve 
the growth kinetics by metabolic engineering have been made (Kannisto et al. 2014). 
On the other hand, neither substrate inhibition nor overflow metabolite production has 
been recognized for ADP1, thus simplifying a bioprocess. Furthermore, the wide 
substrate range provides flexibility in terms of the available feedstocks. However, 
extensive investigations regarding the ADP1 bioprocess optimization need to be 
carried out before steps toward a further process development can be taken. 
Acinetobacter strains are conventionally exploited as model hosts in fundamental 
research regarding microbial genetics, metabolism, or mechanisms related to 
pathogenesis (A. baumannii). My research has introduced new aspects of utilizing the 
strain ADP1 in biotechnology and synthetic biology, and I want to challenge the 
tradition of using E. coli as the only worthy host in modern biosciences. In particular, 
the study reveals the opportunities for the production of fatty acid derived 
biocompounds in ADP1. Although modest improvements were gained in the study, the 
results encourage for further development of the strain for industrial purposes. Thus, I 
hope that my research will serve as a trigger for broader interest toward ADP1 based 
applications. In addition to ADP1 bioprocess development and optimization, I propose 
other acute research targets, such as improving the genomic stability, genome 
streamlining, increased transformation efficiency, engineering of the sugar metabolism, 
and harnessing the broad enzymatic repertoire of ADP1 for developing novel tools for 
synthetic biology.        
While developing an ultimately optimal chassis, the concepts of a minimal cell, a 
completely synthetic cell (Gibson et al. 2010), and an in vitro synthetic biology (Shin 
and Noireaux 2012; Chappell et al. 2013) are emerging. These systems provide a high 
level of programmability, orthogonality, and predictability, and are thus well suited for 
synthetic biology purposes. Is there a possibility that these synthetic platforms displace 
the natural cells in future applications, diminishing the need for further understanding 
about the complexity and behavior of natural cells? Regardless of the host or the 
platform origin, the elegant groundwork of the nature cannot be easily overridden.  
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8 Concluding remarks 
The metabolic diversity and genomic characteristics of A. baylyi ADP1 facilitate the 
strain utilization in synthetic biology applications. The unusual genomic environment 
featured with unique engineering opportunities creates an appealing playground for 
modifying and rewiring the existing pathways and designing new approaches to exploit 
the formable cellular machinery. The natural competence of ADP1 enables straight-
forward genomic insertions, deletions, and modifications in an automated manner, and 
the unique orientation of genes promotes the possibilities for further genomic 
streamlining. The strain ADP1 has been previously shown to be an ideal model host for 
genetic investigations and metabolic studies, and this research further supports the 
findings.  
The metabolic features of ADP1 were exploited in the development of a model platform 
for studying and engineering the long-chain hydrocarbon metabolism. The neutral lipid 
quantity and quality were improved by metabolic engineering and synthetic biology 
means, and ADP1 proved to be a superior platform for developing straight-forward 
tools for studying bacterial hydrocarbon metabolism. The developed monitoring tools 
were shown to fulfill the urgent needs for robust metabolic sensor devices.  
Furthermore, it was shown that ADP1 can serve as a potential counterpart for rationally 
engineered coculture systems, especially in processes involving inhibitory 
concentrations of substrates, metabolites, or toxic compounds. The findings support 
the views of cocultures providing metabolic balance and robustness for bioprocesses, 
and the introduced concept will be further developed in future.   
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Some Acinetobacter spp. have been proposed for industrial production of 
bioemulsifiers and lipases, as well as for bioremediation, biodetoxification, and 
biosensoring purposes in the field of environmental biotechnology. In addition, further 
development and engineering of the strain for the production of neutral lipids, 
especially wax esters, or other high-value hydrocarbons could be profitable, as 
demonstrated here. Nevertheless, to build up truly viable applications, further research 
efforts are required to uncover the mechanisms of the wide-ranging metabolism of A. 
baylyi ADP1. 
In synthetic biology, two trends in creating an optimal chassis hold the field: the other 
approach utilizes the rapidly evolving techniques to construct logic synthetic cells with 
streamlined genomes and programmable features, while the other aims at exploiting 
the natural machineries in the creation of “cyborg cells” with less need for engineering 
and more possibilities for complex designs. In the light of the findings provided by this 
research, A.baylyi ADP1 well represents the latter approach. ADP1 serves a platform 
for the creation of novel and unique metabolic tools and systems by an apt fusion of 
natural and synthetic traits. 
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